<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 201905//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8124914</article-id><article-id pub-id-type="pmid">33946349</article-id><article-id pub-id-type="doi">10.3390/ijms22094771</article-id><article-id pub-id-type="publisher-id">ijms-22-04771</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4851-7650</contrib-id><name><surname>Subedi</surname><given-names>Lalita</given-names></name><xref ref-type="author-notes" rid="fn1-ijms-22-04771">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Gaire</surname><given-names>Bhakta Prasad</given-names></name><xref ref-type="author-notes" rid="fn1-ijms-22-04771">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8044-5613</contrib-id><name><surname>Kim</surname><given-names>Sun-Yeou</given-names></name></contrib><contrib contrib-type="author"><name><surname>Parveen</surname><given-names>Amna</given-names></name><xref rid="c1-ijms-22-04771" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn1-ijms-22-04771">&#x02020;</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Vannucchi</surname><given-names>Maria Giuliana</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-22-04771">College of Pharmacy, Gachon University, #191, Hambakmoero, Yeonsu-gu, Incheon 21936, Korea; <email>subedilali@gmail.com</email> (L.S.); <email>samarpanbp@gmail.com</email> (B.P.G.); <email>sunnykim@gachon.ac.kr</email> (S.-Y.K.)</aff><author-notes><corresp id="c1-ijms-22-04771"><label>*</label>Correspondence: <email>amnaparvin@gmail.com</email>; Tel.: +82-10-5925-2733</corresp><fn id="fn1-ijms-22-04771"><label>&#x02020;</label><p>All authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2021</year></pub-date><volume>22</volume><issue>9</issue><elocation-id>4771</elocation-id><history><date date-type="received"><day>07</day><month>4</month><year>2021</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Nitric oxide (NO) is a neurotransmitter that mediates the activation and inhibition of inflammatory cascades. Even though physiological NO is required for defense against various pathogens, excessive NO can trigger inflammatory signaling and cell death through reactive nitrogen species-induced oxidative stress. Excessive NO production by activated microglial cells is specifically associated with neuroinflammatory and neurodegenerative conditions, such as Alzheimer&#x02019;s and Parkinson&#x02019;s disease, amyotrophic lateral sclerosis, ischemia, hypoxia, multiple sclerosis, and other afflictions of the central nervous system (CNS). Therefore, controlling excessive NO production is a desirable therapeutic strategy for managing various neuroinflammatory disorders. Recently, phytochemicals have attracted considerable attention because of their potential to counteract excessive NO production in CNS disorders. Moreover, phytochemicals and nutraceuticals are typically safe and effective. In this review, we discuss the mechanisms of NO production and its involvement in various neurological disorders, and we revisit a number of recently identified phytochemicals which may act as NO inhibitors. This review may help identify novel potent anti-inflammatory agents that can downregulate NO, specifically during neuroinflammation and neurodegeneration.</p></abstract><kwd-group><kwd>nitric oxide</kwd><kwd>reactive nitrogen species</kwd><kwd>neuroinflammation</kwd><kwd>neurodegeneration</kwd><kwd>phytochemicals</kwd><kwd>medicinal plants</kwd><kwd>plants derivatives</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-22-04771"><title>1. Introduction</title><p>Nitric oxide (NO) is a neurotransmitter with unique biological activity and is synthesized from the amino acid L-arginine [<xref rid="B1-ijms-22-04771" ref-type="bibr">1</xref>]. Three distinct NO synthases (NOSs) facilitate synthesis of NO from L-arginine: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). According to the localization of these NOS enzymes in smooth cells, NO synthesis occurs in macrophages, microglia, astrocytes, neurons, and endothelial cells. NO synthesized in endothelial cells and in the brain (<xref ref-type="fig" rid="ijms-22-04771-f001">Figure 1</xref>) exhibits different biological activities [<xref rid="B2-ijms-22-04771" ref-type="bibr">2</xref>,<xref rid="B3-ijms-22-04771" ref-type="bibr">3</xref>]. NO can cause endothelium-dependent vasodilation, inhibit platelet aggregation, induce immunomodulation, inflammation, and neuronal transmission in the central and peripheral nervous systems. Therefore, the major causes of neurological disorders that are usually observed following high NO production include NO-mediated immune modulation, inflammation, and neurotoxicity [<xref rid="B3-ijms-22-04771" ref-type="bibr">3</xref>]. NO is important for cerebral blood flow and the underlying metabolisms [<xref rid="B4-ijms-22-04771" ref-type="bibr">4</xref>], and it can also play an important role in memory and learning, mediation of nociception, modulation of neuroendocrine functions, and behavioral activity [<xref rid="B5-ijms-22-04771" ref-type="bibr">5</xref>,<xref rid="B6-ijms-22-04771" ref-type="bibr">6</xref>]. Various endotoxins and exotoxins such as lipopolysaccharide, tumor necrosis factor-alpha (TNF-&#x003b1;), interleukin-1B, estrogen, interferon gamma, hypoxic conditions, and ethanol (<xref rid="ijms-22-04771-t001" ref-type="table">Table 1</xref>), can induce microglia and macrophage activation or alter homeostasis, resulting in excessive NO production&#x000a0;which causes harm to the physiological system, the brain, or other parts of the body. In the past few decades, NO was found to play a role in various types of headaches, including primary, vascular (such as migraine), and cluster headaches [<xref rid="B7-ijms-22-04771" ref-type="bibr">7</xref>,<xref rid="B8-ijms-22-04771" ref-type="bibr">8</xref>], and treatment of serotonergic, antimigraine, and other neuroinflammatory disorders with NO inhibitors may provide considerable relief [<xref rid="B9-ijms-22-04771" ref-type="bibr">9</xref>,<xref rid="B10-ijms-22-04771" ref-type="bibr">10</xref>]. NO is involved in several pathophysiological conditions including oxidative damage, neurodegeneration, excitotoxicity, diabetic complications, platelet inhibition, altered smooth muscle relaxation, and cell death through alteration of the functions and pathways of several target proteins, as shown in <xref ref-type="fig" rid="ijms-22-04771-f002">Figure 2</xref>. Medicinal plants are a major reservoir for drug discovery, and the utilization of medicinal plants has been a safe and economic means of treatment of several human ailments since ancient times [<xref rid="B11-ijms-22-04771" ref-type="bibr">11</xref>]. Before the advancement of medicine and technology, people depended on the health effects of medicinal plants for the prevention and treatment of minor and severe conditions. Additionally, at present, a large population segment must rely on medicinal plants to treat diseases, due to poverty and difficulty in procuring medicines for other reasons [<xref rid="B12-ijms-22-04771" ref-type="bibr">12</xref>], and the WHO reported that more than 80% of the population of developing countries depend on traditional medicines [<xref rid="B12-ijms-22-04771" ref-type="bibr">12</xref>]. Medicinal plants including functional foods are known resources for the treatment of several diseases including wounds, inflammation, diabetes, and cancer. Inflammation is one of the most frequent concomitants of disease, and increased NO production by activated microglia in neuronal cells and activated macrophages during non-neuronal inflammation is a key biomarker and a causative factor of several secondary damages. Under such conditions, the inhibition of NO production using medicinal plants or functional foods may help develop novel treatment strategies in the future [<xref rid="B13-ijms-22-04771" ref-type="bibr">13</xref>]. In this review, we discuss useful medicinal plants and their potential to inhibit NO production by activated microglia/macrophages. These medicinal plants and phytochemicals may be thus be used to treat neuronal and non-neuronal inflammatory diseases in humans and animals (<xref rid="ijms-22-04771-t002" ref-type="table">Table 2</xref>).</p><sec id="sec1dot1-ijms-22-04771"><title>1.1. The role of NO in Various Neurological Disorders</title><p>NO is an enzymatic product of NOS and is produced by neurons and endothelial cells in the brain [<xref rid="B14-ijms-22-04771" ref-type="bibr">14</xref>]. It is also a gasotransmitter that easily diffuses across membranes and acts as a vasodilator, neuromodulator, and inflammatory mediator, among other functions [<xref rid="B15-ijms-22-04771" ref-type="bibr">15</xref>]. NO exhibits coordinated effects on brain functions, and substantial evidence suggests that the NO pathway is associated with neurodegenerative disorders such as Alzheimer&#x02019;s disease (AD), dementia, and Lewy body dementia [<xref rid="B14-ijms-22-04771" ref-type="bibr">14</xref>,<xref rid="B16-ijms-22-04771" ref-type="bibr">16</xref>,<xref rid="B17-ijms-22-04771" ref-type="bibr">17</xref>]. NO is released by endothelial cells in the vascular system during aging when cerebral blood flow decreases in the presence of vascular risk factors, resulting in microvasculopathy with impaired NO release, associated with metabolic dysfunction [<xref rid="B14-ijms-22-04771" ref-type="bibr">14</xref>]. NO is a powerful signaling molecule that can be both protective and degenerative. The inducible gene iNOS is responsible for NO production during brain pathologies [<xref rid="B17-ijms-22-04771" ref-type="bibr">17</xref>]. AD pathogenesis involves several key components such as cerebrovasculature, increased inflammation, and alterations in neuronal signaling [<xref rid="B18-ijms-22-04771" ref-type="bibr">18</xref>,<xref rid="B19-ijms-22-04771" ref-type="bibr">19</xref>]. NO is thought to be involved in neuroinflammation because it produces free radicals which affect cellular integrity due to mitochondrial damage. The mechanisms by which A&#x003b2; increases NO production remain unclear; however, oxidative stress is one of the main causes of neuronal function alterations. In AD pathology [<xref rid="B20-ijms-22-04771" ref-type="bibr">20</xref>], NO plays a vital role in signal transduction pathways that are important for maintaining brain, vascular, immune, and muscular functions [<xref rid="B21-ijms-22-04771" ref-type="bibr">21</xref>]. NO can exert both neuroprotective and neurotoxic effects, and studies have suggested that NO may be the cause of neurodegeneration in Parkinson&#x02019;s disease (PD) [<xref rid="B21-ijms-22-04771" ref-type="bibr">21</xref>]. NO causes excitotoxicity, inflammation, and mitochondrial dysfunction, all of which lead to neuronal death [<xref rid="B22-ijms-22-04771" ref-type="bibr">22</xref>]. Levodopa (L-DOPA) is the first drug of choice in PD treatment, even though it does not provide long-term protection or curative effects [<xref rid="B23-ijms-22-04771" ref-type="bibr">23</xref>]. Therefore, therapeutic intervention with NOS inhibitors may be preferable. Furthermore, NO contains a lone pair of electrons with remarkably complex functions in oxidative stress [<xref rid="B24-ijms-22-04771" ref-type="bibr">24</xref>]. NO/iNOS has been shown to play an important role in demyelination, blood&#x02013;brain barrier disruption, and oligodendrocyte and axonal damage, which occur during MS pathology [<xref rid="B24-ijms-22-04771" ref-type="bibr">24</xref>,<xref rid="B25-ijms-22-04771" ref-type="bibr">25</xref>]. Moreover, NO is a gas molecule that plays a key role in blood flow and inflammation during stroke pathology [<xref rid="B26-ijms-22-04771" ref-type="bibr">26</xref>], and a link between increased NO levels in the CSF in brain injury was observed [<xref rid="B27-ijms-22-04771" ref-type="bibr">27</xref>]. Under appropriate conditions, NO can exert protective effects, and such impacts are concentration-dependent [<xref rid="B26-ijms-22-04771" ref-type="bibr">26</xref>]. In the case of amyotrophic lateral sclerosis, motor neuron death is a key pathology, and this process was attributed to oxidative stress due to either ROS/RNS- or NO- and glutamate-induced neurotoxicity. Recently, it has been found that NO is involved in glutamate-induced neuronal death, probably due to the reaction of NO with superoxide anions, which results in tyrosine residue nitration and inhibition of the mitochondrial system and of glutamate transporters [<xref rid="B28-ijms-22-04771" ref-type="bibr">28</xref>]. Furthermore, increased amounts of NO were also found in cases of autism, which may suggest a correlation, and even though the etiology of autism remains unclear, oxidative stress has been reported to play an important role in its pathogenesis, which may be attributable to increase NO production [<xref rid="B29-ijms-22-04771" ref-type="bibr">29</xref>]. Additionally, a growing body of evidence suggests that NO plays a role in synaptic plasticity, and abnormal NO signaling can be linked to a variety of neurodegenerative dysfunctions such as dementia [<xref rid="B30-ijms-22-04771" ref-type="bibr">30</xref>]. NO is reportedly associated with neuropathic pain development [<xref rid="B31-ijms-22-04771" ref-type="bibr">31</xref>], and significant increases in nitrate, nitrite, and NO were found in the sciatic nerve, highlighting the importance of NO as a target in neuropathic pain therapy [<xref rid="B32-ijms-22-04771" ref-type="bibr">32</xref>]. Headache like migraines and vascular headaches are also part of this category. Although the precise cause of migraine pathophysiology remains unknown, evidence suggests a role of NO in migraines [<xref rid="B8-ijms-22-04771" ref-type="bibr">8</xref>,<xref rid="B33-ijms-22-04771" ref-type="bibr">33</xref>,<xref rid="B34-ijms-22-04771" ref-type="bibr">34</xref>]. NO is involved in nociceptive processes, and it appears to be involved in pain transmission as the NO donor glyceryl trinitrate is known to cause headaches [<xref rid="B33-ijms-22-04771" ref-type="bibr">33</xref>]. Therefore, NO inhibition may be a promising strategy for treating migraine and vascular headaches [<xref rid="B35-ijms-22-04771" ref-type="bibr">35</xref>]. NO is crucially associated with various pathological conditions of cells; as a neuromodulator and gaseous molecule, NO is a significant effector in epilepsy. Studies strongly suggest that NO is involved in epileptic seizures [<xref rid="B36-ijms-22-04771" ref-type="bibr">36</xref>,<xref rid="B37-ijms-22-04771" ref-type="bibr">37</xref>], and anticonvulsants are currently used in epilepsy treatments. Similarly, a direct association of neuropathic pain and the pathogenic impact of NO was revealed; neuropathic pain is a complex interaction between peripheral axons, sensory neurons, and the central nervous system (CNS) [<xref rid="B38-ijms-22-04771" ref-type="bibr">38</xref>]. In addition to its key role in disease pathology, NO is critical regarding complications caused by inflammatory cascades due to diabetes, AIDS, and sequelae of lupus erythematosus (SLE). Increased release of NO or NO dysfunction may be associated with diabetic neuropathy [<xref rid="B39-ijms-22-04771" ref-type="bibr">39</xref>]. Similarly, the main reasons for the pathogenesis of diabetic retinopathy, which is a leading cause of blindness and visual disfunction, include oxidative stress, nitrosative stress, and increased NO concentrations [<xref rid="B40-ijms-22-04771" ref-type="bibr">40</xref>]. Furthermore, the majority of AIDS patients suffer from neurological complications where NO plays a significant role in the host&#x02019;s defense system [<xref rid="B41-ijms-22-04771" ref-type="bibr">41</xref>,<xref rid="B42-ijms-22-04771" ref-type="bibr">42</xref>]. Moreover, NO overproduction directly leads to HIV-I infection-associated dementia. The protein HIV-I Tat was observed to induce iNOS expression, which results in dementia [<xref rid="B41-ijms-22-04771" ref-type="bibr">41</xref>]. NO peroxynitrite-mediated nitrosative stress causes reduced immune functioning and associated neurological complications in conditions such as Lyme neuroborreliosis [<xref rid="B43-ijms-22-04771" ref-type="bibr">43</xref>]. SLE is an inflammatory disease associated with neurological symptoms, thus NO plays a crucial role in its pathogenesis. Increased levels of nitrite and nitrate have been associated with neurological symptoms [<xref rid="B44-ijms-22-04771" ref-type="bibr">44</xref>] in the brain and after spinal cord injury (SCI). NO affects blood flow control, and iNOS and nNOS upregulation are involved in cardiovascular disease. Increased NO production has been observed in patients with SCI, which is of interest as NO affects the prevention of blood coagulation [<xref rid="B45-ijms-22-04771" ref-type="bibr">45</xref>,<xref rid="B46-ijms-22-04771" ref-type="bibr">46</xref>,<xref rid="B47-ijms-22-04771" ref-type="bibr">47</xref>]. Furthermore, increased NO production after SCI results in neuronal loss due to oxidative damage [<xref rid="B47-ijms-22-04771" ref-type="bibr">47</xref>], and excessive NO production by activated glial cells is the main cause of potentiated neuroinflammation in diverse CNS disorders [<xref rid="B13-ijms-22-04771" ref-type="bibr">13</xref>,<xref rid="B48-ijms-22-04771" ref-type="bibr">48</xref>]. Therefore, controlling excessive NO production may be a promising strategy for the treatment of neuroinflammatory disorders.</p><table-wrap id="ijms-22-04771-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-22-04771-t001_Table 1</object-id><label>Table 1</label><caption><p>Factors which may induce NO production in different cell types.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Stimulator
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Cell Type
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
References
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine microglia (BV2), primary microglia, and RAW cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-ijms-22-04771" ref-type="bibr">49</xref>,<xref rid="B50-ijms-22-04771" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macrophages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-ijms-22-04771" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
IL-1&#x003b2;
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Murine N9 microglia
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-ijms-22-04771" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Estrogen
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Human umbilical vein cells (HUVEC) and human neuroblastoma cells (SK-N-SH)
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-ijms-22-04771" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
IFN-&#x003b3;
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Macrophages
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-ijms-22-04771" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Hypoxia
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat insulinoma cell line (INS-1), rat islet cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-ijms-22-04771" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Ethanol
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Hypothalamic neuronal cell cultures
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-ijms-22-04771" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Advanced glycation end products
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
BV2 cells, endothelial cells
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-ijms-22-04771" ref-type="bibr">56</xref>]</td></tr></tbody></table></table-wrap></sec><sec id="sec1dot2-ijms-22-04771"><title>1.2. Anti-Neuroinflammatory and NO-Inhibiting Activity of Lignans and Neolignans</title><p>Balanophonin: <italic>Firmiana simplex</italic> (Malvaceae) is commonly found in China and South Korea; in North America, it is a popular ornamental tree, and in South Korea, it is traditionally used to treat stomach disorders and diarrhea. Balanophonin, an active constituent isolated from this plant, reduces NO production and expression of PGE2, TNF-&#x003b1;, IL-1&#x003b2;, and COX2, and it downregulates the MAPK, ERK, JNK, and p38 MAPK pathways. Furthermore, it suppresses neuronal cell death by regulating PARP cleavage in N2a cells. These findings support the role of balaniphonin in inhibiting neuroinflammation [<xref rid="B57-ijms-22-04771" ref-type="bibr">57</xref>].</p><p>Chaenomiside A: <italic>Chaenomeles sinensis</italic> (Rosaceae) mainly occurs in East Asian countries including China, Japan, and South Korea, and this plant&#x02019;s fruit is traditionally used to treat inflammatory diseases, diarrhea, and throat ailments. The main bioactive components of this plant are chainomisides A and C which exert various pharmacological functions such as antiviral, antidiabetic, antihyperglycemic, antioxidant, and antihyperlipidemic activities. Recently, it has been shown that chainomiside A is the main bioactive constituent inhibiting NO production and exerting anti-neuroinflammatory effects [<xref rid="B58-ijms-22-04771" ref-type="bibr">58</xref>].</p><p>Dihydrobenzo(b) furan neolignan (7R, 8S)-dehydrodiconferyl: <italic>Clematis armandii</italic> (Ranunculaceae) is traditionally used to treat inflammation-related diseases such as rheumatism and urinary tract infections. This plant is common in the Northern Hemisphere, and phytochemical studies have shown that it contains steroids and lignans with pharmacological properties including anti-inflammatory and anti-aging effects. Erythro-guaiac glycerol-&#x003b2;-conifer ether and (7R, 8S)-dehydrodiconferyl alcohol are the two bioactive constituents (dihydrobenzo(b)furan neolignans) isolated from this plant which reduce NO production and inhibit TNF-&#x003b1; expression in LPS-activated BV2 cells, indicating the potential use of this plant and its compounds in treating neuroinflammatory diseases [<xref rid="B59-ijms-22-04771" ref-type="bibr">59</xref>]. (7R, 8S)-dehydrodiconferyl alcohol inhibits COX-2 and iNOS expression, suppresses NF-&#x003ba;B activation, and inhibits AKT, JNK, Src, and fak phosphorylation [<xref rid="B60-ijms-22-04771" ref-type="bibr">60</xref>].</p><p>Lignanamides (melongenamide C and cannabisin F): <italic>Solanum melongena</italic> L (Solanaceae) is common in the subtropical and tropical regions, and its unripe fruit is commonly used as a vegetable while roots are used medicinally to cure toothache, pruritus, hemorrhoids, beriberi, and chilblains. Several pharmacological activities of this plant have been reported, including improved blood circulation and hypnotic, sedative, analgesic, and anti-inflammatory effects. Melongenamide C and cannabisin F are the two most active lignanamides of this plant and exhibit inhibitory activity against NO generation, indicating that these compounds can be used to treat neuroinflammatory diseases [<xref rid="B61-ijms-22-04771" ref-type="bibr">61</xref>].</p><p>Lignanoside: <italic>Selagginella tamariscina</italic> (Selaginellaceae) is common in tropical and subtropical regions, and in folk medicine, it is used to improve blood circulation and to treat cancer, inflammatory disorders, cardiovascular diseases, and diabetes. The crude extract inhibits cellular expression of NO, iNOS, TNF-&#x003b1;, and NF-&#x003ba;B. The plant contains several active secondary metabolites, and (2R, 3S) dihydro-2-(3,5-dimethoxy-4-hydroxyphenyl)-7-methoxy-5-acetyl-benzofuran and tamariscinoside E are the two bioactive constituents that exhibit significant suppression of NO generation in LPS-stimulated RAW 264.7 cells. These findings indicate that the plant and its constituents can be a source of anti-inflammatory agents to treat inflammatory diseases, including neuroinflammation [<xref rid="B62-ijms-22-04771" ref-type="bibr">62</xref>].</p><p>Sambucuside: <italic>Sambucus williamsii</italic> (Adoxaceae) is traditionally used to treat gastrointestinal disorders, bone and joint diseases, and kidney-related diseases. It shows various pharmacological and biological activities, including hypolipidemic, antiviral, antinociceptive, anticancer, antiglycemic, antifungal, and antioxidant effects. Furthermore, studies suggested that it facilitates differentiation of pluripotent stem cells into neurons. Recently, three new compounds termed sumbucuside B, C, and E were isolated from this plant, which belong to the lignan family and show promising anti-inflammatory anti-neuroinflammatory effects due to inhibition of NO production [<xref rid="B63-ijms-22-04771" ref-type="bibr">63</xref>].</p></sec><sec id="sec1dot3-ijms-22-04771"><title>1.3. Anti-Neuroinflammatory and NO-Inhibiting Effects of Flavonoids</title><p>Cudraflavanone A: <italic>Cudrania tricuspidata</italic> Bureau (Moraceae) is traditionally used to treat various disorders as it is a rich source of bioactive chemicals with potential pharmacological effects, including anti-inflammatory, neuroprotective, and antioxidant activities. Cudraflavanone A, an active component of this plant, exerts anti-neuroinflammatory effects by preventing NO, PGE2, and iNOS production in LPS-stimulated BV2 cells, and it inactivates the NF-&#x003ba;B, P38, and JNK MAPK signaling pathways. In addition, this compound induces HO-1 expression through Nrf2 translocation; however, no effect on the expression of COX-2 protein was observed. These findings indicate that cudraflavanone A can be potentially used to inhibit neuroinflammation and to prevent neurodegenerative diseases [<xref rid="B64-ijms-22-04771" ref-type="bibr">64</xref>].</p><p>Daidzein: <italic>Glycine max</italic> (Fabaceae) is commonly known as soybean. Several scientific studies have been conducted to examine the traditional use of this plant, including osteoporosis prevention and cholesterol-lowering, anticancer, antidiabetic, anti-inflammatory effects. After consumption of soybean, polysaccharide fatty acids are converted into docosahexaenoic acids, which are associated with various beneficial effects on the kidney and on inflammatory disorders. Daidzein, a major active isoflavone, exhibits anti-inflammatory activity in neurological disorders through the inhibition of NO production in LPS-stimulated models, and it may cure neurological disorders by inhibiting the expression of proinflammatory cytokines, chemokines, interleukin-6 mRNA, and monocyte chemoattractant protein-1 [<xref rid="B65-ijms-22-04771" ref-type="bibr">65</xref>,<xref rid="B66-ijms-22-04771" ref-type="bibr">66</xref>,<xref rid="B67-ijms-22-04771" ref-type="bibr">67</xref>].</p><p>Eupatilin: <italic>Artemisia asiatica</italic> (Asteraceae) is traditionally used in Asia to treat inflammatory diseases, and may also be of use for curing other conditions including liver injury, pancreatic damage, and gastric ulcers by acting on the NF-&#x003ba;B pathways. In South Korea, it is used to treat gastric mucosal ulcers. Eupatilin, a major bioactive constituent, was suggested to exhibit various pharmacological activities such as anti-inflammatory and antioxidant effects, according to various in vitro and in vivo studies. It regulates activated microglia in transient focal cerebral ischemia and exerts beneficial effects on inflammation [<xref rid="B68-ijms-22-04771" ref-type="bibr">68</xref>].</p><p>Genistein: Soybean is a staple food in Asian countries and a source of oil and proteins for humans and animals. It contains phytoestrogens which have been used to treat several hormone-dependent and -independent pathologies, including a variety of cancers such as breast, prostate, and colon cancer, as well as other diseases such as obesity, cardiovascular disease, Alzheimer&#x02019;s disease, and osteoporosis. Genistein, a bioactive constituent, has been shown to exert anti-inflammatory effects during neurological disorders through NO inhibition, and it inhibits NF-&#x003ba;B, proinflammatory cytokines, and the activation of AMP kinase, thereby exerting anti-inflammatory effects [<xref rid="B65-ijms-22-04771" ref-type="bibr">65</xref>,<xref rid="B69-ijms-22-04771" ref-type="bibr">69</xref>].</p><p>Orobol 4&#x02032;-O-&#x003b2;-D-apiofuranosyl-(1&#x02192;6)-&#x003b2;-D-glucopyranoside: <italic>Tilia amurensis</italic> (Tiliacea) is commonly termed &#x0201c;bee tree&#x0201d; and is widely distributed in Japan, South Korea, China, and Russia. The leaves of this plant are used to treat cancer. Tea from this plant&#x02019;s flowers is frequently consumed due to its sedative, diaphoretic, and antispasmodic properties. Orobol 4&#x02032;-O-&#x003b2;-D-apiofuranosyl-(1&#x02192;6)-&#x003b2;-D-glucopyranoside, an isoflavonoid isolated from this plant, was examined regarding its neuroprotective activity against neurodegenerative diseases, and among several secondary metabolites isolated from this plant, this compound showed the most promising inhibition effects on NO production in LPS-stimulated BV2 cells [<xref rid="B70-ijms-22-04771" ref-type="bibr">70</xref>].</p><p>Quercetin: <italic>Impatiens balsamina</italic> (Balsaminaceae) is widely distributed in India, China, and South Korea. It has a long history of use for treating contact dermatitis, scalds, burns, neuralgia, and lumbago. Several pharmacological studies have supported its therapeutic potential as an antioxidant, anticancer, anti-nociceptive, anti-inflammatory, anti-anaphylactic, and anti-pyretic agent due to its high active flavonoid content. Quercetin is one of the major active secondary metabolites that has been evaluated for its neuroprotective activity. These results indicate that <italic>I. balsamina</italic> is a new source of an anti-neuroinflammatory natural compounds that inhibit NO production in LPS-stimulated BV2 cells. Furthermore, quercetin regulates brain nitrite levels to counteract the activity of several oxidases and elicits antidepressant and inflammatory responses [<xref rid="B71-ijms-22-04771" ref-type="bibr">71</xref>].</p><p>Sophoraflavanone G: <italic>Sophora alopecuroides</italic> (Fabaceae) is traditionally used in China to treat pain, inflammation, and fever. Sophoraflavanone G is the main secondary metabolite isolated from this plant and has been shown to exhibit anti-inflammatory effects. <italic>S. alopecuroides</italic> has been evaluated for its neuroinflammatory activity in LPS-stimulated BV2 cell; it downregulated the expression of NO, PGE2, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6. Further studies revealed the effects of this plant can be attributed to the presence of sophoraflavanone G. Additionally, sophoraflavanone G inhibits the expression of iNOS and COX-2, downregulates the JAK/STAT, P13K/AKT, and MAPK pathways, and upregulates oxygenase-1 expression. Taken together, these results suggest that sophoraflavanone G can be potentially used as an anti-neuroinflammatory agent [<xref rid="B72-ijms-22-04771" ref-type="bibr">72</xref>].</p><p>Tangeretin: <italic>Citrus aurantium</italic> (Rutaceae), commonly known as bitter orange, is widely distributed throughout Asia. Medicinally, this plant is consumed as an appetite suppressant and stimulant; however, in traditional Chinese medicine, it is used to treat cardiovascular diseases, cancer, constipation, indigestion, and nausea. This plant may counteract lung cancer due to the presence of tangeretin, an active constituent. The effects of tangeretin on neuroinflammation suggest that it inhibits neurodegenerative disorders by inhibiting NO, IL-1&#x003b2;, COX-2, MAPK, NF-&#x003ba;B, IkB-&#x003b1;, and IKK-&#x003b2; in LPS-stimulated BV2 cells, thereby counteracting neurodegenerative diseases [<xref rid="B73-ijms-22-04771" ref-type="bibr">73</xref>].</p></sec><sec id="sec1dot4-ijms-22-04771"><title>1.4. Anti-Neuroinflammatory and NO-Inhibiting Activity of Polyphenols</title><p>Butein: <italic>Toxicodendron verniciflumm</italic> (Anacardiaceae) is traditionally used as a food supplement in folk medicine to treat dyspepsia, heartburn, abdominal infection, bronchitis, arthritis, cancer, and inflammatory disorders in South Korea. Several pharmacological activities of this plant have been reported, including apoptosis, anticancer, and antioxidant activities. This plant is a rich source of secondary metabolites such as polyphenols and flavonoids which have anticancer and anti-inflammatory properties. Buetin, one of the most active constituents present in this plant, predominantly inhibits NO production in LPS-stimulated BV2 cells [<xref rid="B74-ijms-22-04771" ref-type="bibr">74</xref>].</p><p>(4E,6E)-1-(3&#x02032;,4&#x02032;-dihydroxyphenyl)-7-(4&#x02033;-hydroxyphenyl)-hepta-4,6-dien-3-one, and Tsaokarylone: <italic>Dioscorea nipponica</italic> (Dioscoreaceae) is used traditionally in South Korea to treat diabetes, neurodegenerative diseases, chronic fatigue, loss of appetite, malnutrition, and inflammatory disorders. 3,7-dihydroxy-2,4,6-trimethoxy-phenanthrene is a bioactive constituent isolated from this plant which can counteract neurodegenerative diseases. It not only induces nerve growth factor expression but also inhibits NO production in LPS-stimulated BV2 cells without cell toxicity. In addition, it predominantly suppresses elevated neurite outgrowth in N2a cells [<xref rid="B75-ijms-22-04771" ref-type="bibr">75</xref>].</p><p>Gingerol: <italic>Zingiber officinale</italic> (Zingiberaceae) is a common ingredient in food and is valued for its use in treatments of various pathological conditions associated with brain aging and neurodegeneration. Ginger contains various bioactive constituents including gingerol and its dehydrating products such as shogaol. Gingerol and shogaol exert various pharmacological effects, including antioxidant, anti-inflammatory, chemopreventive, cardiotonic, and antipyretic activities. Ginger extract inhibits NO production and proinflammatory cytokines through the NF-&#x003ba;B pathway, and it reduces B-amyloid-induced oxidative cell death. Moreover, gingerol and shogaol produced from ginger are active, and some ingredients such as zingerone and 6-gingerol inhibit NO production, IL-6, IL-1&#x003b2;, TNF-&#x003b1;, and mRNA levels in BV2 microglial cells activated by LPS. Fresh ginger extracts also exert anti-neuroinflammatory properties due to the presence of 10-gingerol. These observations suggest the potential of ginger and its bioactive constituents regarding anti-inflammatory effects in neurodegenerative diseases by suppressing NO production [<xref rid="B76-ijms-22-04771" ref-type="bibr">76</xref>].</p><p>Oleuropein: <italic>Fraxinus rhynchophylla</italic> (Oleaceae) is distributed in several areas of the world, including eastern and western France, China, India, Pakistan, Morocco, and Afghanistan. <italic>F. rhynchophylla</italic> is traditionally used to treat pneumonia and malaria, and oleuropein, a major bioactive constituent isolated from this plant, has been investigated to determine its anti-neuroinflammatory activity exerted through inhibition of NO and ROS production and ERK/p38/NF-&#x003ba;B activation. Furthermore, it inhibits Drp1-dependent mitochondrial fission induced by LPS. These findings highlight the therapeutic value of oleuropein in microglial inflammation-regulated neurodegenerative afflictions [<xref rid="B77-ijms-22-04771" ref-type="bibr">77</xref>].</p><p>Paradol: Paradol, a biotransformed metabolite of shogaol, ameliorates neuroinflammation and CNS disorders. It markedly lowers microglial activation, TNF-&#x003b1;, and iNOS expression, and ultimately reduces neuroinflammation, indicating its potential for treating cerebral ischemia [<xref rid="B78-ijms-22-04771" ref-type="bibr">78</xref>].</p><p>Salicortin: <italic>Salix glandulosa</italic> (Salicaceae) is commonly known as Korean King willow in South Korea. Salicortin, a bioactive salicin derivative, is the most effective constituent isolated from this plant; it exhibits inhibitory activity against NO production, and shows potency with respect to the treatment of neuroinflammation in LPS-stimulated BV2 cells [<xref rid="B79-ijms-22-04771" ref-type="bibr">79</xref>].</p><p>Shogaol: 6-shogaol is a bioactive constituent of <italic>Zingiber officinale</italic> and can be potentially used to treat several CNS disorders. It inhibits NO and inducible nitric oxide synthase in LPS models, and it exhibits neuroprotective effects in animals with transient global ischemia through suppression of microglia. Furthermore, it enhances the expression of acetyltransferase and choline transport and protects neurons. These findings support the use of ginger in multitarget therapies for Alzheimer&#x02019;s disease [<xref rid="B80-ijms-22-04771" ref-type="bibr">80</xref>].</p><p>Zingerone: Zingerone, a bioactive constituent present in cooked ginger, may have anti-inflammatory effects as it significantly lowers the levels of proinflammatory cytokines and enzymes involved in cartilage degradation [<xref rid="B81-ijms-22-04771" ref-type="bibr">81</xref>], and it attenuates LPS-induced changes in IL-1&#x003b2;, IL-6, TNF-&#x003b1;, creatinine, blood nitrogen urea, and kidney histopathology and reduces NF-&#x003ba;B, TLR4, MyD88, and TRIF expression. These effects indicate a suppressive role of zingerone in LPS-induced AKI by inhibiting the TLR4/NF-&#x003ba;B signaling pathway [<xref rid="B82-ijms-22-04771" ref-type="bibr">82</xref>].</p></sec><sec id="sec1dot5-ijms-22-04771"><title>1.5. Anti-Neuroinflammatory and NO-Inhibiting Activity of Triterpenoids</title><p>Alphitolic acid: Alphitolic acid is present in leaves of <italic>Alphitonia petriei</italic> (<italic>Rhamnaceae</italic>) and also in <italic>Ziziphus jajuba</italic> fruit, commonly termed &#x0201c;jujube&#x0201d;, &#x0201c;red date&#x0201d;, or &#x0201c;Chinese date&#x0201d;. In China, jujube is considered one of the most valuable fruits, and it has various traditional benefits, including calming the mind and improving sleep. Jujube contains valuable secondary metabolites that exert potential pharmacological and biological effects including sedative, antioxidant, and immunological effects. The effects of aliphatic acid, an active constituent in the fruit of this plant, on NO inhibition were examined in LPS-induced and LPS- and IFN-&#x003b3;-mediated microglia and macrophages&#x02019; activation and in a neuro-inflammation model, which suggested anti-neuroinflammatory properties [<xref rid="B83-ijms-22-04771" ref-type="bibr">83</xref>,<xref rid="B84-ijms-22-04771" ref-type="bibr">84</xref>].</p><p>Betulinic acid and coussaric acid are produced by <italic>Diospyros kaki</italic> Thunb., distributed in East Asian countries, and <italic>Chaenomeles</italic> sp. <italic>D. kaki</italic> leaves are typically used to produce tea. Betulinic and coussaric acid exhibit therapeutic value as anti-inflammatory agents through the inhibition of the NF-&#x003ba;B pathway, and they reduce NO production and prostaglandin E2, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, and COX-2 concentrations. These findings indicate therapeutic value of both agents against neuroinflammation [<xref rid="B85-ijms-22-04771" ref-type="bibr">85</xref>].</p><p>Corosolic acid and ambradiolic acid: <italic>Betula schmidtii</italic> (Betulaceae) is widely distributed in China, Japan, and South Korea. In traditional Korean medicine, this plant is used to treat stomach disorders. Phytochemical screening revealed that corsolic and ambradiloic acid are the two main active constituents, which exert several biological and pharmacological activities, including antioxidant, anti-inflammatory, immunomodulatory, anticancer, and hepatoprotective activities. In neuroinflammatory disorders, NO production is inhibited by these compounds without signs of cytotoxicity [<xref rid="B86-ijms-22-04771" ref-type="bibr">86</xref>].</p><p>Faurinone: <italic>Lindera glauca</italic> (Lauraceae) a widely distributed shrub in China, Japan, and South Korea which is used to treat several pathological conditions such as speech disorder, abdominal pain, and paralysis. This compound may inhibit NO production without cytotoxic effects [<xref rid="B87-ijms-22-04771" ref-type="bibr">87</xref>] as shown in <xref rid="ijms-22-04771-t002" ref-type="table">Table 2</xref>.</p><p>23-hydroxybetulinic acid: <italic>Chaenomeles speciosa</italic> (Rosaceae) is common in East, Central, and Southwest China. Traditionally, the fruit of this plant is used to harmonize the stomach, relax tendons and muscles, and prevent several clinical conditions including migraine, neuralgia, beriberi, dysentery, cholera, and rheumatism. Due to the fruit&#x02019;s traditional use, several pharmacological studies have been conducted to examine its therapeutic value. 23-hydroxybetulinic acid, a bioactive constituent isolated from this plant, exerts substantial effects against LPS-induced inflammation, suggesting its efficacy as an anti-inflammatory agent [<xref rid="B88-ijms-22-04771" ref-type="bibr">88</xref>].</p><p>Holophyllane A: <italic>Abies holophylla</italic> Maxim. (Pinaceae) is used by traditional healers to treat various diseases including stomach ache, rheumatic diseases, indigestion, and pulmonary and vascular diseases. This plant is a rich source of steroids, phenols, flavonoids, lignans, and terpenoids which exert different pharmacological effects such as anti-inflammatory, antifungal, anti-bacterial, and anticancer activities. This plant is widely distributed in Russia, China, and South Korea and is considered a source of various active compounds. Recently, a novel bioactive compound, holophyllane A, was isolated, which exhibits anti-inflammatory activity through inhibition of NO production; however, further studies are required to explore mechanisms underlying its anti-inflammatory effects [<xref rid="B89-ijms-22-04771" ref-type="bibr">89</xref>].</p><p>Ilimaquinone: <italic>Smenospongia cerebriformis</italic>, a marine sponge, is a prominent source of secondary constituents with potential biological and pharmacological activities with diverse structures. Several pharmacological activities have been examined to explore the potential therapeutic value of this sponge, including its anticancer and anti-depressant effects. Ilimaquinon, the main active constituent isolated from this sponge, can suppress the proliferation of multiple myeloma cells and exert anti-inflammatory effects. Recently, we determined such anti-inflammatory effects by inhibiting NO production during LPS-induced inflammation in BV2 microglia cells, suggesting the therapeutic value of this compound in neuroinflammatory diseases [<xref rid="B90-ijms-22-04771" ref-type="bibr">90</xref>].</p><p>Maslinic acid: <italic>Olea euroopaea</italic> L. (Oleaceae) is the most prominent member of the genus <italic>Olea</italic> and the only member of its family that is consumed as food. It is most common in the Mediterranean region, and its fruits are important in the context of religion, as olives are mentioned in different holy books such as the Bible and the Quran. The therapeutic potential of the fruits is also acknowledged in traditional medicine, as they can lower uric acid, cholesterol, and blood sugar levels. Products of this plant have been used traditionally as laxatives and mouth wash and to treat diabetes, rheumatism, hemorrhoids, asthma, gastrointestinal, respiratory afflictions, and urinary tract infections. Many phenolic compounds of this plant have been investigated in the past century, and maslinic acid, an active constituent isolated from olive pomace, is associated with a reduction in the occurrence of inflammation-related diseases. Various in vitro and in vivo studies indicate that maslinic acid reduces NO production, NOS mRNA, and protein expression stimulated by LPS. It also suppresses expression of TNF-&#x003b1;, NF-&#x003ba;B, and COX-2, which suggests the therapeutic value of maslinic acid to reduce neuroinflammation [<xref rid="B91-ijms-22-04771" ref-type="bibr">91</xref>].</p><p>Saikosaponins: <italic>Bupleurum falcatum</italic> L. (Umbellifers) is traditionally used to treat autoimmune diseases and chronic hepatitis. Several active secondary metabolites have been identified in this plant, including polyacetylene, flavonoids, triterpenoids, polysaccharides, and saikosaponins. Saikosaponins (saikosaponin B3, B4, and D) are considered this plant&#x02019;s major active chemicals due to several pharmacological activities including immunomodulatory, antibacterial, anti-inflammatory, and antihepatoma effects. In LPS-stimulated BV2 cells of inflammation models, saikosaponins inhibit NO production and expression of inflammatory marker genes including TNF-&#x003b1;, IL-6, IL-1&#x003b2;, iNOS, and NF-&#x003ba;B/real. Saikosaponin B3 was found to be less cytotoxic than other saikosaponins. Taken together, these results suggest that <italic>B. falcatum</italic> ameliorates neuroinflammatory diseases due to the presence of saikosaponins [<xref rid="B92-ijms-22-04771" ref-type="bibr">92</xref>].</p><p>Sesquiterpene dimer: <italic>Artemisia argyi</italic> H. (Asteraceae) has a long history of use in traditional Chinese medicine due to including anti-inflammatory, anticancer, antioxidant, and antidiabetic properties effects. Sesquiterpene dimer (DSF-52), a novel sesquiterpene dimer, is present in this plant and has been investigated for its anti-neuroinflammatory activity, revealing the potency of this compound. Sesquiterpene dimers inhibit NO, PGE2, TNF-&#x003b1;, IL-1&#x003b2;, GM-CSF, and MIP-1&#x003b1;. It also downregulates the p38 MAPK and JNK, JAK2/STAT3-dependent inflammation pathways. This suggests the potency of this compound [<xref rid="B93-ijms-22-04771" ref-type="bibr">93</xref>].</p><p>Spathulenol: The genus <italic>Phaeanthus</italic> (Annonaceae) is distributed widely throughout tropical Asia. <italic>P. vietnamensis</italic> is an endemic species from Vietnam and has been used to treat several inflammatory diseases, including sore red eyes, diarrhea, abdominal pain, and pimples. This plant is considered important as it is used to season different food products. Spathulenol, a bioactive constituent isolated from this plant, showed considerable activity against NO production upon LPS stimulation, suggesting the potential value of this compound for treating neurodegenerative diseases [<xref rid="B94-ijms-22-04771" ref-type="bibr">94</xref>].</p></sec><sec id="sec1dot6-ijms-22-04771"><title>1.6. Anti-Neuroinflammatory and NO-Inhibiting Activity of Phytoestrogens</title><p>Coumestrol: <italic>Medicago sativa</italic> Linn. (Fabaceae) belongs to the legumes, is sometimes referred to as &#x0201c;father of all foods&#x0201d;, and originates from Asia. It is cultivated globally for various purposes, including medicinal uses, as animal feed, and for soil improvement. This plant has a long history of being used in America, India, Turkey, Iraq, and China to treat various digestive and central nervous system disorders. Various pharmacological activities have been studied, including lowering liver cholesterol accumulation and effects on hyperglycemia and neurodegenerative menopausal symptoms. Various secondary metabolites isolated from this plant exhibit interesting nutraceutical and medicinal properties. Coumestrol is the main phytoestrogen metabolite which can inhibit neurological disorders by reducing NO production. It inhibits neurological disorders by downregulating iNOS, interferon regulatory factor-1, stat1, MCP-1, and IL-6 expression [<xref rid="B95-ijms-22-04771" ref-type="bibr">95</xref>].</p></sec><sec id="sec1dot7-ijms-22-04771"><title>1.7. Anti-Neuroinflammatory and NO-Inhibiting Activity of Coumarins</title><p>Omphalocarpin: <italic>Toddaliae asiaticae</italic> (Rutaceae) is commonly found in China and is traditionally used to cure rheumatism, intercostal neuralgia, trauma pain, stomach disorders, cough, indigestion, and bold-circulation. This plant contains different secondary metabolites including alkaloids and coumarins with antifungal, antibacterial, anti-HIV, antiplasmodial, and anti-platelet aggregation effects. Omphalocarpin, an active constituent of this plant, inhibits the expression of proinflammatory mediators, such as NO, TNF-&#x003b1;, and IL-1&#x003b2; and downregulates COX-2 and NOS expression in LPS-stimulated BV2 cells. Omphalocarpin in <italic>T. asiatica</italic> is an active anti-inflammatory agent which may be used for treating neurodegenerative diseases [<xref rid="B96-ijms-22-04771" ref-type="bibr">96</xref>].</p></sec><sec id="sec1dot8-ijms-22-04771"><title>1.8. Anti-Inflammatory and NO-Inhibiting Activity of other Compounds</title><p>Aucuparin and dihydromentosolic acid: <italic>Chaenomeles speciosa</italic> (Rosaceae) is distributed in China and South Korea, and it is traditionally used to treat common cold, hepatitis, and rheumatoid arthritis. This plant&#x02019;s fruit was suggested to be a rich source of terpenoids, tannins, and flavonoids that are linked to its biological activity as an antioxidant, antimicrobial, and anti-inflammatory. Lignan and triterpenoid glycosides isolated from twigs of this plant exhibited significant anti-inflammatory activity by regulating IL-6, IL-1&#x003b2;, and TNF-&#x003b1; in LPS-induced cells. Aucuparin and dihydromentosolic acid are the two bioactive components of this plant that are responsible for suppressing NO production in LPS-induced models without cytotoxicity, suggesting that this plant and its bioactive constituents may inhibit neuroinflammation and may be a source of anti-inflammatory agents [<xref rid="B88-ijms-22-04771" ref-type="bibr">88</xref>].</p><p>&#x003b5;-Cotonefuran: <italic>Contoneaster</italic> sp. (Rosaceae) is a common ornamental shrub producing &#x003b5;-cotonefuran which has antifungal properties. Recently, &#x003b5;-cotonefuran was also confirmed to occur in <italic>Chaenomeles sinensis</italic> which is known to have therapeutic potential due to its anti-inflammatory effects, and the anti-inflammatory activities of this compound were examined. It exhibits substantial inhibiting effects on NO production in LPS-activated BV2 cells. These findings suggest that this compound may be a new anti-neuroinflammatory agent, which, however, requires further studies [<xref rid="B97-ijms-22-04771" ref-type="bibr">97</xref>].</p><p>Citrusin XI: <italic>Citrus unshiu</italic> (Rutaceae) is traditionally used to treat fatigue, cough, bronchitis, influenza, and various cancers and to improve skin elasticity. It is primarily cultivated on Jeju Island, South Korea, and in the southern regions of Japan and China. Citrus XI, an active cyclopeptide identified in <italic>C. unshiu</italic> fruit, exhibits anti-neuroinflammatory effects by suppressing NO production through inhibition of iNOS and NF-&#x003ba;B expression in LPS-activated RAW 264.7 cells. This suggests the potential of this plant for use in treating neurodegenerative diseases [<xref rid="B98-ijms-22-04771" ref-type="bibr">98</xref>].</p><p>Koaburaside: <italic>Lindera neesiana</italic> (Lauraceae) is consumed as food, and essential oil of its fruit contains large amounts of z-citral, eucalyptol, and &#x003b1;-pinene. Traditionally, this plant is consumed to cure tooth pain, headache, gastric disorders, and diarrhea. It is widely distributed in Myanmar, Nepal, India, Bhutan, and China. Koaburaside, a major bioactive constituent, shows anti-inflammatory activity during LPS-induced inflammation by inhibiting NO production. In addition, it inhibits inflammatory signaling proteins such as MAPK, COX-2, and INOS [<xref rid="B99-ijms-22-04771" ref-type="bibr">99</xref>].</p><p>Sinapoyl desulfoglucoraphenin: <italic>Raphanus sativus</italic> (Brassicaceae), commonly known as radish, is consumed as a condiment or vegetable. This plant has a long history of being used as a Chinese medicine to stimulate digestion, bile flow, and appetite. Traditional healers use it to treat cancer, inflammation, asthma, and stomach ailments. Sinapoyl desulfoglucoraphenin is a bioactive secondary metabolite that inhibits NO production in LPS-stimulated BV2 cells. Furthermore, it can also downregulate the expression of iNOS and inhibit the tumor-inhibiting activity in HC5-15 cells. This suggests that <italic>R. sativus</italic> is not only useful for inhibiting neurodegenerative diseases but may be useful for treating cancer [<xref rid="B100-ijms-22-04771" ref-type="bibr">100</xref>].</p><p>Zanthplanispine: <italic>Zanthoxylum schinifolium</italic> (Rutaceae) is distributed in Japan, South Korea, and China. Traditionally, it is used to improve blood circulation and to relieve pain. The fruit is used as a spice in the local cuisine of Asia. Zanthplanispine, a typical tetrahydrofuran lignin isolated from the root of this plant, inhibits NO production in LPS-stimulated RAW 264.7 cells, indicating the therapeutic value of this plant as a source of anti-neuroinflammatory agents [<xref rid="B101-ijms-22-04771" ref-type="bibr">101</xref>].</p><table-wrap id="ijms-22-04771-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-22-04771-t002_Table 2</object-id><label>Table 2</label><caption><p>List of phytochemicals that inhibit NO production and neuroinflammation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Scientific Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC50</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Class</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Abies holophylla</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Holophyllane A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.75</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Triterpenoid</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NO</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Anticancer</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B89-ijms-22-04771" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Holophyllane B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.96</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia argyi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesquiterpene dimer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NO, PGE2, TNF-&#x003b1;, IL-1&#x003b2;, GM-CSF, MIP-1&#x003b1;, p38 MAPKs., JNK, JAK2/STAT3
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammation<break/>Anticancer<break/>Antioxidant<break/>Antidiabetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-ijms-22-04771" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia asiatica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eupatilin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF-&#x003ba;B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory<break/>Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-ijms-22-04771" ref-type="bibr">68</xref>]</td></tr><tr><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Betula schmidtii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x003b1;-O-benzoyl-3&#x003b2;,19&#x003b1;-dihydroxy-urs-12-en-28-oic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.92</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Triterpenoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B86-ijms-22-04771" ref-type="bibr">86</xref>,<xref rid="B102-ijms-22-04771" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x003b1;-O-benzoyl-19&#x003b1;-hydroxy-3-oxo-urs-12-en-28-oic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corosolic acid<break/>11-Oxo-erythrodiol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.93<break/>16.58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maslinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-&#x003b1;, NF-&#x003ba;B, a COX-2, NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morolic acid 3-<italic>O</italic>-caffeate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ambradiolic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isotachioside 4-allyl-2-hydrophenyl 1-O-&#x003b2;-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
23.9
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Phenolic derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
D-apiosyl-(1 &#x02192; 6)-
&#x003b2;
-D-glucopyranoside
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
25.3
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein 5-O-&#x003b2;-D-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
28.8
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Prunetinoside
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
34.0
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Brassica olifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulforaphane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
5.85
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">isothiocyanate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory<break/>Antioxidant<break/>Anti-amnesic<break/>Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-ijms-22-04771" ref-type="bibr">56</xref>,<xref rid="B103-ijms-22-04771" ref-type="bibr">103</xref>,<xref rid="B104-ijms-22-04771" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bupleurum falcatum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saikosaponins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, TNF-&#x003b1;, IL-6, IL-1&#x003b2;, iNOS, NF-&#x003ba;B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Immune modulator<break/>
Antibacterial<break/>
Anti-inflammatory<break/>
Antihepatoma
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-ijms-22-04771" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Capsella Bursa-pastoris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesquilignan glycoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75.13</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Phenolic glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B105-ijms-22-04771" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7S, 8R, 8&#x02032;R-(&#x02212;)-lariciresinol-4,4&#x02032;-bis-O-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lariciresinol4&#x02032;-O-&#x003b2;-d-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Pinoresinol-&#x003b2;-d-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salidroside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-(4-&#x003b2;-D-glucopyranosyloxy-3,5-dimethoxy)-phenyl-2E-propanol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Hydroxy-propiovanillone 3-O-&#x003b2;-d-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coniferin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Chaenomeles sinensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-O-cis-feruloyl-2&#x003b1;,19&#x003b1;- dihydroxyurs-12-en-28-oic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.1</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Triterpenoids</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NO</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B106-ijms-22-04771" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maslinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x003b1;,3&#x003b1;-Dihydroxyolean-12-en-28-oic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x003b1;-Hydroxyursolic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Betulinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF-&#x003ba;B, NO, prostaglandin E2, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, COX-2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alphitolic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.5</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-O-cis-caffeoylbetulinic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilekudinol C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chaenomin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berbekorin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-Hydroxyaucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-Methoxyaucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;,4&#x02032;-Dimethoxyaucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b5;-Cotonefuran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Chaenomeles speciosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chaenomin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">283.33</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Biphenyl derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anticancer<break/>Anti-inflammatory<break/>Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-ijms-22-04771" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chaenomin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;,4&#x02032;-Dimethoxyaucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">272.72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-Methoxyaucuparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maslinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydrotomentosolic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilexgenin B,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Betulinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF-&#x003ba;B, NO, prostaglandin E2, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, COX-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23-Hydroxybetulinic acid and pycarenic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pycarenic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus aurantium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tangeretin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-neuroinflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-ijms-22-04771" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus unshiu</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citrusin XI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclopeptide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, iNOS, NF-&#x003ba;B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory<break/>Anti-fungal<break/>Anti-bacterial<break/>Antioxidant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-ijms-22-04771" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Clematis armandii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(7R, 8S)-dehydrodiconferyl alcohol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, COX-2, iNOS, NF-&#x003ba;B, AKT, JNK, src, fak</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-aging<break/>Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-ijms-22-04771" ref-type="bibr">59</xref>,<xref rid="B60-ijms-22-04771" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cudrania tricuspidata Bureau</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cudraflavanone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, PGE2, iNOS, NF-&#x003ba;B, P38, JNK MAPK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory Neuroprotective<break/>Antioxidant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-ijms-22-04771" ref-type="bibr">64</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Dioscorea nipponica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tsaokarylone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.36</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Phenols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-diabetic<break/>Anti-inflammatory</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B75-ijms-22-04771" ref-type="bibr">75</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>4E,6E</italic>)-1-(3&#x002b9;,4&#x002b9;-dihydroxyphenyl)-7-(4&#x002b9;&#x002b9;-hydroxyphenyl)-hepta-4, 6-dien-3-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="19" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Firmiana simplex</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-[(1S,2R)-1,3-dihydroxy-2-[4-[(1E)-3-hydroxy-1-propenyl]-2- methoxyphenoxy] propyl]-2-methoxyphenyl &#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
59.83
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignan glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, PGE2, TNF-&#x003b1;, IL-1&#x003b2;, COX2, MAPKs, ERK, JNK, p38 MAPK</td><td rowspan="19" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-neuroinflammatory<break/>Anti-inflammatory<break/>Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-ijms-22-04771" ref-type="bibr">107</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balanophonin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neolignan derivative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="18" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B57-ijms-22-04771" ref-type="bibr">57</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firmianols A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.39</td><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Lignan derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firmianols B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Piperitol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Pinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Syringaresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Buddlenol E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Sesamin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-Pinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-7&#x02032;-Methoxylariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-5-Methoxybalanophonin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Buddlenol A <italic>Threo</italic>-(7<italic>R</italic>,8<italic>R</italic>)-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guaiacylglycerol-&#x003b2;-coniferyl aldehyde ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Erythro</italic>-(7<italic>S</italic>,8<italic>R</italic>)-Guaiacylglycerol-&#x003b2;-coniferyl aldehyde ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.929</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Threo</italic>-Guaiacylglycerol-8-<italic>O</italic>-4&#x02032;-sinapyl alcohol ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Erythro</italic>-Syringylglycerol-8-<italic>O</italic>-4&#x02032;-coniferyl alcohol ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Threo</italic>-Guaiacylglycerol-8-<italic>O</italic>-4&#x02032;-coniferyl alcohol ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Threo</italic>-Guaiacylglycerol 8&#x02032;-vanillin ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>
Fraxinus rhynchophylla
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleuropein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NO, ROS, ERK/p38/NF-&#x003ba;B
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-ijms-22-04771" ref-type="bibr">77</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Glycine max</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daidzein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.15</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Isoflavones</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NO, AMP kinase, NF-&#x003ba;B</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory Neuroprotective</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B65-ijms-22-04771" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daidzein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.09</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137.50</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.63</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Equol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.45</td></tr><tr><td rowspan="13" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Impatiens balsamina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balsamisides A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.33</td><td rowspan="13" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Biflavonoid glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="13" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-neurodegenerative</td><td rowspan="13" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B71-ijms-22-04771" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balsamisides B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balsamisides C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balsamisides D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol 3-O-&#x003b2;-D-glucopyranoside,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Kaempferol3-O-&#x003b1;-L-rhamnopyranosyl-(1&#x02192;2)-&#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Kaempferol3-O-&#x003b1;-L-rhamnopyranosyl-(1&#x02192;6)-&#x003b2;-Dglucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Kaempferol 3-O-&#x003b2;-D-allopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.35<break/>19.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin3-O-&#x003b2;-D-glucospyranoide,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin3-O-&#x003b1;-L-rhamnopyranosyl-(1&#x02192;6)-&#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydromyricetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Lagerstroemia indica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pterospermin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.4</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Phenolic derivative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B108-ijms-22-04771" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydrodehydroconiferyl alcohol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alatusol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ficusol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Evofolin-B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marphenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Ligustrum obtusifolium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Obtusifolisides A
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.85</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Secoiridoid glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">LPS-activated microglia<break/>neuroinflammation</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B109-ijms-22-04771" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Obtusifolisides B
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleoside-11-methylester</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleoside-7,11-dimethylester<break/>10-Hydroxyoleuropein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.89<break/>11.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleuropein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ligstroside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(2&#x02033;R)-2&#x02033;- methoxyoleuropein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neonuezhenide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4,4&#x02032;-(1E,1&#x02032;E,3E,3&#x02032;E)-3,3&#x02032;-(hydrazine-1,2-diylidene) bis-(prop-1-ene-1-yl-3-ylidene) bis-(2-methoxyphenol)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azine derivative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-ijms-22-04771" ref-type="bibr">110</xref>]</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Lindera glauca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eudeglaucone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.90</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Eudesmane sesquiterpene</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B87-ijms-22-04771" ref-type="bibr">87</xref>,<xref rid="B111-ijms-22-04771" ref-type="bibr">111</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Faurinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.67</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b1;-Hydroxycostic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilicic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b3;-Costic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lindera neesiana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Koaburaside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic glycoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, MAPK, COX-2, INOS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory, Neuroprotection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-ijms-22-04771" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Medicago sativa Linn</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coumestrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phytoestrogen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, 1 (IRF-1), stat1, MCP-1, IL-6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antidiabetic<break/>Lower liver cholesterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-ijms-22-04771" ref-type="bibr">95</xref>]</td></tr><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Phaeanthus vietnamensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(7S,8R,8&#x02032;R)-9,9&#x02032;-epoxy-3,5,3&#x02032;,5&#x02032;-tetramethoxylignan-4,4&#x02032;,7-triol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.2</td><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B94-ijms-22-04771" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8R,8&#x02032;R-bishydrosyringenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-5,5&#x02019;-Dimethoxylariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Pinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8&#x003b1;-Hydroxyoplop-11(12)-en-14-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spathulenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x003b1;H,5&#x003b2;H-aromandendrane-4&#x003b2;,10&#x003b1;-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x003b1;H,5&#x003b2;H-aromandendrane-4&#x003b1;,10&#x003b1;-diol10&#x003b1;-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x003b2;H,5&#x003b2;H-aromandendrane-4&#x003b1;,10&#x003b2;-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b1;,4&#x003b2;-dihydroxybisabola-1,10-diene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1R,2S,4S)-4-acetyl-2-[(E)-(cinnamoyloxy)]-1-methylcyclohexan-1-ol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pinus koraiensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Koraiensides E
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
24.1
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpenoid Glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory<break/>Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-ijms-22-04771" ref-type="bibr">112</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Raphanus sativus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sinapoyl desulfoglucoraphenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.36</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">4-Methylthio-butanyl derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Anti-proliferative</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B100-ijms-22-04771" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Equol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Salix glandulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saliglandin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120.18</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Salicin derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="15" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B79-ijms-22-04771" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x02032;-O-(Z)-p-coumaroylsalicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-<italic>O</italic>-acetylsalicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123.36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02032;-<italic>O</italic>-acetylsalicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fragilin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">206.12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trumuloidin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-<italic>O</italic>-(<italic>E</italic>)-<italic>p</italic>-coumaroylsalicin<break/>2&#x02032;-<italic>O</italic>-(<italic>Z</italic>)-<italic>p</italic>-coumaroylsalicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.77<break/>25.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x02032;-O-(<italic>E</italic>)-<italic>p</italic>-coumaroylsalicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salicortin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;-<italic>O</italic>-acetylsalicortin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.61</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02032;-<italic>O</italic>-acetylsalicortin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x02032;-<italic>O</italic>-acetylsalicortin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tremulacin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cochinchiside A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Sambucus williamsii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sambucasinol B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">New iridoid glycosides<break/>Lignan</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NO</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Neuroprotective</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B63-ijms-22-04771" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sambucuside C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sambucuside E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sambucasinol A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.82</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.58</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(7&#x003b1;H,8&#x02032;&#x003b1;H)-4,4&#x02032;,8&#x003b1;,9-tetrahydroxy-3,3&#x02032;-dimethoxy-7,9&#x02032;-epoxylignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;500</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berchemol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">215.41</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7-Hydroxylariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128.97</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-Medioresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.59</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-Pinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.25</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7R,8S-dihydrodehydrodiconiferyl alcohol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.97</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Selagginella tamariscina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
(2R, 3S) dihydro-2-(3,5-dimethoxy-4-hydroxyphenyl)-7-methoxy-5-acetyl-benzofuran
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.3</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Lignanoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NO, iNOS, TNF-&#x003b1;, and NF-&#x003ba;B
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B62-ijms-22-04771" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Tamariscinoside E
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Smenospongia cerebriformis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smenohaimiens A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.13</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Sesquiterpene derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B90-ijms-22-04771" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smenohaimiens B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smenohaimiens C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smenohaimiens D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smenohaimiens E<break/>19-Hydroxy-polyfibrospongol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.37<break/>24.44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilimaquinone,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dictyoceratin C,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyfibrospongol A,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyfibrospongol B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Solanum melongena L</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melongenamide C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.4</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Lignanamides</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NO</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B61-ijms-22-04771" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cannabisin F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sophora alopecuroides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sophoraflavanone G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NO, PGE2, TNF-&#x003b1;, IL-1&#x003b2;, IL-6, iNOS, COX-2, JAK/STAT, P13K/AKT, MAPKs
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-neuroinflammatory </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-ijms-22-04771" ref-type="bibr">72</xref>]</td></tr><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Sorbus commixta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sorcomisides A </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Phenolic glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Neuroprotective<break/>Anticancer </td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B113-ijms-22-04771" ref-type="bibr">113</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sorcomisides B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sorcomic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180.12</td><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Fatty Acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Neuroprotective<break/>Anticancer </td><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B114-ijms-22-04771" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyl (3S,5S)-3,5-dihydroxyhexanoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">165.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(S)-(E)-4-hydroxy-2-nonenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3(R)-hydroxyoctanoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-Hydroxynonanoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">187.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyl 9-hydroxynonanoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">196.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azelaric acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150.22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monomethyl azelate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9S,12S,13R)-(E)-9,12,13-trihydroxy-10-octadecaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">186.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9S,12R,13R)-(E)-9,12,13-trihydroxy-10-octadecaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Tilia amurensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Orobol4&#x02019;-O-&#x003b2;-D-apiofuranosyl-(1&#x02192;6)-&#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.42</td><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Isoflavonoid glycoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-neuroinflammatory<break/>Anti-proliferative</td><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B70-ijms-22-04771" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Pratensein-7-O-&#x003b2;- D-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Orobol 7-O-&#x003b2;-D-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Orobol 4&#x02032;-O-&#x003b2;-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Kelampayoside A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osmanthuside H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salidroside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydroconiferin </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">158.49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isotachioside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tachioside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Koaburside </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> 2-Methoxyhydroquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Scopoletin </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Scopolin </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">148.92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Fraxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> n-Butyl &#x003b2;-D-glucopyranoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Adenosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Toddaliae asiaticae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Omphalocarpin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phytoestrogen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, TNF-&#x003b1;, IL-1&#x003b2;, COX-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-ijms-22-04771" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Toxicodendron verniciflumm</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Butein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
11.68
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic<break/>Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-22-04771" ref-type="bibr">74</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Ulmus davidiana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fraxetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
18.72
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">chromane derivative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory Neuroprotective </td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B115-ijms-22-04771" ref-type="bibr">115</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-lyoniresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
12.31
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-O-&#x003b2;-D-glucopyranosyl vanillic acid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
21.40
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Wasabi japonica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allyl isothiocyanate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aliphatic isothiocyanate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-activated microglia<break/>neuroinflammation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B116-ijms-22-04771" ref-type="bibr">116</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Zanthoxylum schinifolium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zanthplanispine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
36.8
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-ijms-22-04771" ref-type="bibr">101</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>
Zinginber officinale
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gingerols </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Polyphenols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO, NF-&#x003ba;B, IL-6, IL-1&#x003b2;, TNF-&#x003b1;</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory<break/>Neuroprotective</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B76-ijms-22-04771" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gingerone </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shogaol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zingerone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
IL-1&#x003b2;, IL-6, TNF-&#x003b1;, NF-&#x003ba;B, TLR4, MyD88, TRIF
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paradol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
NA
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
TNF-&#x003b1;, iNOS
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Honokiol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
17.0
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyrazole analogs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-ijms-22-04771" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-NMMA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
20.53
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyl-arginine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-ijms-22-04771" ref-type="bibr">89</xref>]</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="intro" id="sec2-ijms-22-04771"><title>2. Discussion and Future Prospective</title><p>Natural products and their derivatives are rich sources of active and novel compounds that may be used against several adverse conditions including cancers, diabetes, inflammatory diseases, metabolic diseases, neurological diseases, and many others [<xref rid="B118-ijms-22-04771" ref-type="bibr">118</xref>,<xref rid="B119-ijms-22-04771" ref-type="bibr">119</xref>,<xref rid="B120-ijms-22-04771" ref-type="bibr">120</xref>,<xref rid="B121-ijms-22-04771" ref-type="bibr">121</xref>,<xref rid="B122-ijms-22-04771" ref-type="bibr">122</xref>,<xref rid="B123-ijms-22-04771" ref-type="bibr">123</xref>,<xref rid="B124-ijms-22-04771" ref-type="bibr">124</xref>]. NO, a unique biological neurotransmitter, is involved in the initiation of several biological and pathological conditions, including immunomodulation, inflammation, and neuronal transmission in the central and peripheral nervous systems, which may lead to neurological disorders. Potential candidates that target the NO-interlinked signaling pathways have been screened and were identified from different natural products and their derivatives. We summarized our previous studies, and we suggest that these plants and their respective phytochemicals may be potential candidates for treating neuroinflammation when NO plays an important role as shown in (<xref ref-type="fig" rid="ijms-22-04771-f003">Figure 3</xref>, <xref ref-type="fig" rid="ijms-22-04771-f004">Figure 4</xref> and <xref ref-type="fig" rid="ijms-22-04771-f005">Figure 5</xref>). Based on our evaluation, <xref rid="ijms-22-04771-t003" ref-type="table">Table 3</xref> shows that these products are more potent than standard compounds, and we elucidate several interesting facts and findings regarding these constituents and their natural resources (<xref rid="ijms-22-04771-t001" ref-type="table">Table 1</xref> and <xref rid="ijms-22-04771-t002" ref-type="table">Table 2</xref>).</p><p>This review suggests that we should consider these candidates for future prospects targeting their deep signaling pathway, clinical study, safety, and formulation. For example, <italic>Sambucus williamsii</italic> contains sambucasinol B, the most potent candidate to use for treating neuroinflammation which has been identified and explored recently; however, no further studies have been conducted [<xref rid="B63-ijms-22-04771" ref-type="bibr">63</xref>].</p><p>Although some potential candidates are effective anti-neuroinflammatory agents, due to their other pharmacological effects, they may not be indicated. For example, <italic>Clematis armandii</italic> contains Erythro-guaiac glycerol-&#x003b2;-conifer ether and (7R, 8S)-dehydrodiconferyl alcohol which are anti-neuroinflammatory drugs that should not be used during pregnancy as they promote urination. Therefore, caution should be exercised when considering the use of natural resources [<xref rid="B57-ijms-22-04771" ref-type="bibr">57</xref>].</p><p><italic>Diospyros kaki</italic> Thunb. has been cultivated for many years in Asian countries such as Japan, China, and South Korea, and its leaves, containing betulinic acid, have been used to produce green tea in many countries; the leaves are not toxic, which can be attributed to different bioactive compounds. Therefore, health authorities should consider this plant a part of anti-neuroinflammatory therapy [<xref rid="B85-ijms-22-04771" ref-type="bibr">85</xref>]. Soybean is also a commonly used plant which contains a potent anti-neuroinflammatory agent that may be used to treat patients with neuroinflammatory diseases [<xref rid="B65-ijms-22-04771" ref-type="bibr">65</xref>]. <italic>Lindera glauca</italic> containing faurinone is used against cancer and neuroinflammation, thus, it can be used to treat two pathological conditions at a time to reduce the economic burden on patients while promoting patient compliance [<xref rid="B87-ijms-22-04771" ref-type="bibr">87</xref>].</p><p>Several candidate compounds and their natural sources are not only effective against neurological disorders but also against other pathological conditions. Remarkable therapeutic success has been achieved using these candidates in patients with different diseases; for example, <italic>Sambucus williamsii</italic>, which contains sambucasinol B, has been traditionally used to treat bone fractures and osteoporosis [<xref rid="B63-ijms-22-04771" ref-type="bibr">63</xref>].</p><p>NO plays an important role in maintaining body functions. Excessive production of NO can lead to the initiation of various diseases and complications, including platelet inhibition, oxidative damage, cell death, diabetic complications, endothelial dysfunction, and neutrophil activation, which are interlinked with several signaling pathways and pharmacological targets such as iNOS, TNF-&#x003b1;, TRIF, MYD88, IL-1&#x003b2;, IL-6, COX-2, MAPKs, JAK/STAT, PGE2, MCR-1, ERK, and ROS. There are some natural products that have been studied only regarding their effects on NO production; however, future studies should explore the underlying mechanisms. Examples include holophyllane A, maslinic acid, aucuparin, &#x003b5;-cotyfuran, spathulenol, sinapoyl desulfoglucoraphenin, saliglandin, salicortin, scambucasinol B, melongenamide C, and zanthplanispine [<xref rid="B79-ijms-22-04771" ref-type="bibr">79</xref>,<xref rid="B88-ijms-22-04771" ref-type="bibr">88</xref>,<xref rid="B89-ijms-22-04771" ref-type="bibr">89</xref>,<xref rid="B94-ijms-22-04771" ref-type="bibr">94</xref>].</p><p>Structure activity relationship (SAR) plays a vital role in predicting biological activity based on molecular structure and identifying potential bioactive constituents. SAR analysis is a powerful technology for drug discovery and provides a guideline for the synthesis of new potential compounds along with the characterization of already available molecules. Based on our review, we suggest that SAR plays an important role in biological activity. <xref ref-type="fig" rid="ijms-22-04771-f003">Figure 3</xref>, <xref ref-type="fig" rid="ijms-22-04771-f004">Figure 4</xref> and <xref ref-type="fig" rid="ijms-22-04771-f005">Figure 5</xref> show the structures of all compounds.</p><p>The inhibition effect of orobol 4&#x002b9;-O-&#x003b2;- D-apiofuranosyl -(1&#x02192;6)-&#x003b2;-D-glucopyranoside (<xref ref-type="fig" rid="ijms-22-04771-f003">Figure 3</xref>) on NO generation is likely due to the addition of a &#x003b2;-D-apiofuranosyl-(1&#x02192;6)- group to the C-4 hydroxyl group through glycosylation [<xref rid="B70-ijms-22-04771" ref-type="bibr">70</xref>]. The anti-inflammatory activity of gingerol (<xref ref-type="fig" rid="ijms-22-04771-f004">Figure 4</xref>) is attributed to its alkyl side chain [<xref rid="B76-ijms-22-04771" ref-type="bibr">76</xref>]. In the case of shogaol and paradol, chain length plays an important role regarding its biological activity and pharmacokinetic properties [<xref rid="B78-ijms-22-04771" ref-type="bibr">78</xref>,<xref rid="B80-ijms-22-04771" ref-type="bibr">80</xref>]. The 1-hydroxy-6-oxocyclohex-2-en-1-yl) carboxylate substructure at the C-7 position of salicortin (<xref ref-type="fig" rid="ijms-22-04771-f004">Figure 4</xref>) may be responsible for its NO-inhibiting effect [<xref rid="B79-ijms-22-04771" ref-type="bibr">79</xref>]. The presence of hydroxyl at the C-14 position of ilimaquinone (<xref ref-type="fig" rid="ijms-22-04771-f005">Figure 5</xref>) played an important role regarding its prominent anti-inflammatory effects [<xref rid="B90-ijms-22-04771" ref-type="bibr">90</xref>]. Molecular docking studies of masilinic acid showed that due to hydrogen bonding and hydrophobic interaction, it binds to the sPLA<sub>2-</sub> GV interfacial phospholipid binding site and inhibits sPLA<sub>2-</sub> GV enzymatic activity in the inflammatory signaling pathway [<xref rid="B91-ijms-22-04771" ref-type="bibr">91</xref>]. At the C-8 position, an exomethylene group was attached to the compound spathulenol, which showed strong inhibitory effects on NO production [<xref rid="B94-ijms-22-04771" ref-type="bibr">94</xref>]. The ester group of zanthplanispine may be responsible for its strong anti-inflammatory activity [<xref rid="B101-ijms-22-04771" ref-type="bibr">101</xref>].</p><p>Structure&#x02013;activity relationship analyses revealed that a compound&#x02019;s structure plays an important role regarding its biological activity. By identifying therapeutically active compounds, new derivatives can be prepared, and stronger potential agents with fewer side effects can be obtained.</p><p>In our collaborative work with other research, we aimed to identify potential NO inhibitors over the past few years. Here, we summarize many of our findings, and among them, few are high-potency agents compared to the well-known iNOS inhibitors, based on IC50 values (<xref rid="ijms-22-04771-t003" ref-type="table">Table 3</xref>).</p><p>In conclusion, it is conceivable that addition of phytochemicals in the context of daily diet or consuming them as supplements can help reduce neuroinflammation or prevent its occurrence.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>L.S. and B.P.G. helped in writing, editing, methodology and data collection the manuscript with the help of A.P.; A.P. and S.-Y.K. reviewed and supervised the whole work. Moreover, A.P. funded the whole work. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF2019R1G1A1003693).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-22-04771"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuriyama</surname><given-names>K.</given-names></name><name><surname>Ohkuma</surname><given-names>S.</given-names></name></person-group><article-title>Role of nitric oxide in central synaptic transmission: Effects on neurotransmitter release</article-title><source>Jpn. J. Pharmacol.</source><year>1995</year><volume>69</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1254/jjp.69.1</pub-id><pub-id pub-id-type="pmid">8847826</pub-id></element-citation></ref><ref id="B2-ijms-22-04771"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luiking</surname><given-names>Y.C.</given-names></name><name><surname>Engelen</surname><given-names>M.P.</given-names></name><name><surname>Deutz</surname><given-names>N.E.</given-names></name></person-group><article-title>Regulation of nitric oxide production in health and disease</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2010</year><volume>13</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e328332f99d</pub-id><?supplied-pmid 19841582?><pub-id pub-id-type="pmid">19841582</pub-id></element-citation></ref><ref id="B3-ijms-22-04771"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forstermann</surname><given-names>U.</given-names></name><name><surname>Sessa</surname><given-names>W.C.</given-names></name></person-group><article-title>Nitric oxide synthases: Regulation and function</article-title><source>Eur. Heart J.</source><year>2012</year><volume>33</volume><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehr304</pub-id><?supplied-pmid 21890489?><pub-id pub-id-type="pmid">21890489</pub-id></element-citation></ref><ref id="B4-ijms-22-04771"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toda</surname><given-names>N.</given-names></name><name><surname>Ayajiki</surname><given-names>K.</given-names></name><name><surname>Okamura</surname><given-names>T.</given-names></name></person-group><article-title>Cerebral blood flow regulation by nitric oxide in neurological disorders</article-title><source>Can. J. Physiol. Pharmacol.</source><year>2009</year><volume>87</volume><fpage>581</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1139/Y09-048</pub-id><?supplied-pmid 19767882?><pub-id pub-id-type="pmid">19767882</pub-id></element-citation></ref><ref id="B5-ijms-22-04771"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esplugues</surname><given-names>J.V.</given-names></name></person-group><article-title>NO as a signalling molecule in the nervous system</article-title><source>Br. J. Pharmacol.</source><year>2002</year><volume>135</volume><fpage>1079</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0704569</pub-id><pub-id pub-id-type="pmid">11877313</pub-id></element-citation></ref><ref id="B6-ijms-22-04771"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garthwaite</surname><given-names>J.</given-names></name></person-group><article-title>Concepts of neural nitric oxide-mediated transmission</article-title><source>Eur. J. Neurosci.</source><year>2008</year><volume>27</volume><fpage>2783</fpage><lpage>2802</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06285.x</pub-id><pub-id pub-id-type="pmid">18588525</pub-id></element-citation></ref><ref id="B7-ijms-22-04771"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashina</surname><given-names>M.</given-names></name><name><surname>Bendtsen</surname><given-names>L.</given-names></name><name><surname>Jensen</surname><given-names>R.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group><article-title>Nitric oxide-induced headache in patients with chronic tension-type headache</article-title><source>Brain</source><year>2000</year><volume>123</volume><fpage>1830</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1093/brain/123.9.1830</pub-id><pub-id pub-id-type="pmid">10960046</pub-id></element-citation></ref><ref id="B8-ijms-22-04771"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group><article-title>The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache</article-title><source>Pharmacol. Ther.</source><year>2008</year><volume>120</volume><fpage>157</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.08.003</pub-id><pub-id pub-id-type="pmid">18789357</pub-id></element-citation></ref><ref id="B9-ijms-22-04771"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Nahas</surname><given-names>S.J.</given-names></name><name><surname>Peterlin</surname><given-names>B.L.</given-names></name></person-group><article-title>Chemical mediators of migraine: Preclinical and clinical observations</article-title><source>Headache</source><year>2011</year><volume>51</volume><fpage>1029</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.01929.x</pub-id><pub-id pub-id-type="pmid">21631491</pub-id></element-citation></ref><ref id="B10-ijms-22-04771"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>J.N.</given-names></name><name><surname>Al-Omran</surname><given-names>A.</given-names></name><name><surname>Parvathy</surname><given-names>S.S.</given-names></name></person-group><article-title>Role of nitric oxide in inflammatory diseases</article-title><source>Inflammopharmacology</source><year>2007</year><volume>15</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1007/s10787-007-0013-x</pub-id><pub-id pub-id-type="pmid">18236016</pub-id></element-citation></ref><ref id="B11-ijms-22-04771"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaire</surname><given-names>B.P.</given-names></name></person-group><article-title>Herbal medicine in ischemic stroke: Challenges and prospective</article-title><source>Chin. J. Integr. Med.</source><year>2018</year><volume>24</volume><fpage>243</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1007/s11655-018-2828-2</pub-id><?supplied-pmid 29696521?><pub-id pub-id-type="pmid">29696521</pub-id></element-citation></ref><ref id="B12-ijms-22-04771"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name></person-group><article-title>Medicinal plant diversity and their pharmacological aspects of Nepal Himalayas</article-title><source>Pharm. J.</source><year>2011</year><volume>3</volume><fpage>6</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.5530/pj.2011.25.2</pub-id></element-citation></ref><ref id="B13-ijms-22-04771"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name></person-group><article-title>Sphingosine 1-phosphate receptors in cerebral ischemia</article-title><source>Neuromol. Med.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1007/s12017-020-08614-2</pub-id><?supplied-pmid 32914259?><pub-id pub-id-type="pmid">32914259</pub-id></element-citation></ref><ref id="B14-ijms-22-04771"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togo</surname><given-names>T.</given-names></name><name><surname>Katsuse</surname><given-names>O.</given-names></name><name><surname>Iseki</surname><given-names>E.</given-names></name></person-group><article-title>Nitric oxide pathways in Alzheimer&#x02019;s disease and other neurodegenerative dementias</article-title><source>Neurol. Res.</source><year>2004</year><volume>26</volume><fpage>563</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1179/016164104225016236</pub-id><?supplied-pmid 15265275?><pub-id pub-id-type="pmid">15265275</pub-id></element-citation></ref><ref id="B15-ijms-22-04771"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balez</surname><given-names>R.</given-names></name><name><surname>Ooi</surname><given-names>L.</given-names></name></person-group><article-title>Getting to NO Alzheimer&#x02019;s Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide</article-title><source>Oxid. Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><pub-id pub-id-type="doi">10.1155/2016/3806157</pub-id></element-citation></ref><ref id="B16-ijms-22-04771"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>S.A.</given-names></name><name><surname>Santhanam</surname><given-names>A.V.</given-names></name><name><surname>Hinton</surname><given-names>D.J.</given-names></name><name><surname>Choi</surname><given-names>D.S.</given-names></name><name><surname>Katusic</surname><given-names>Z.S.</given-names></name></person-group><article-title>Endothelial nitric oxide deficiency promotes Alzheimer&#x02019;s disease pathology</article-title><source>J. Neurochem.</source><year>2013</year><volume>127</volume><fpage>691</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1111/jnc.12334</pub-id><?supplied-pmid 23745722?><pub-id pub-id-type="pmid">23745722</pub-id></element-citation></ref><ref id="B17-ijms-22-04771"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montagne</surname><given-names>A.</given-names></name><name><surname>Barnes</surname><given-names>S.R.</given-names></name><name><surname>Sweeney</surname><given-names>M.D.</given-names></name><name><surname>Halliday</surname><given-names>M.R.</given-names></name><name><surname>Sagare</surname><given-names>A.P.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Toga</surname><given-names>A.W.</given-names></name><name><surname>Jacobs</surname><given-names>R.E.</given-names></name><name><surname>Liu</surname><given-names>C.Y.</given-names></name><name><surname>Amezcua</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Blood-brain barrier breakdown in the aging human hippocampus</article-title><source>Neuron</source><year>2015</year><volume>85</volume><fpage>296</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.032</pub-id><pub-id pub-id-type="pmid">25611508</pub-id></element-citation></ref><ref id="B18-ijms-22-04771"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>M.P.</given-names></name></person-group><article-title>Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer&#x02019;s disease</article-title><source>J. Neurovirol.</source><year>2002</year><volume>8</volume><fpage>539</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1080/13550280290100978</pub-id><pub-id pub-id-type="pmid">12476348</pub-id></element-citation></ref><ref id="B19-ijms-22-04771"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>M.M.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Vaibhav</surname><given-names>K.</given-names></name><name><surname>Ahmad</surname><given-names>M.E.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Ashafaq</surname><given-names>M.</given-names></name><name><surname>Islam</surname><given-names>F.</given-names></name><name><surname>Siddiqui</surname><given-names>M.S.</given-names></name><name><surname>Safhi</surname><given-names>M.M.</given-names></name><etal/></person-group><article-title>Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type</article-title><source>Neuroscience</source><year>2012</year><volume>210</volume><fpage>340</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.02.046</pub-id><pub-id pub-id-type="pmid">22441036</pub-id></element-citation></ref><ref id="B20-ijms-22-04771"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spuch</surname><given-names>C.</given-names></name><name><surname>Ortolano</surname><given-names>S.</given-names></name><name><surname>Navarro</surname><given-names>C.</given-names></name></person-group><article-title>New insights in the amyloid-Beta interaction with mitochondria</article-title><source>J. Aging Res.</source><year>2012</year><volume>2012</volume><pub-id pub-id-type="doi">10.1155/2012/324968</pub-id></element-citation></ref><ref id="B21-ijms-22-04771"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Dawson</surname><given-names>V.L.</given-names></name><name><surname>Dawson</surname><given-names>T.M.</given-names></name></person-group><article-title>Role of nitric oxide in Parkinson&#x02019;s disease</article-title><source>Pharmacol. Ther.</source><year>2006</year><volume>109</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.05.007</pub-id><?supplied-pmid 16005074?><pub-id pub-id-type="pmid">16005074</pub-id></element-citation></ref><ref id="B22-ijms-22-04771"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquilano</surname><given-names>K.</given-names></name><name><surname>Baldelli</surname><given-names>S.</given-names></name><name><surname>Rotilio</surname><given-names>G.</given-names></name><name><surname>Ciriolo</surname><given-names>M.R.</given-names></name></person-group><article-title>Role of nitric oxide synthases in Parkinson&#x02019;s disease: A review on the antioxidant and anti-inflammatory activity of polyphenols</article-title><source>Neurochem. Res.</source><year>2008</year><volume>33</volume><fpage>2416</fpage><lpage>2426</lpage><pub-id pub-id-type="doi">10.1007/s11064-008-9697-6</pub-id><?supplied-pmid 18415676?><pub-id pub-id-type="pmid">18415676</pub-id></element-citation></ref><ref id="B23-ijms-22-04771"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yacoubian</surname><given-names>T.A.</given-names></name><name><surname>Standaert</surname><given-names>D.G.</given-names></name></person-group><article-title>Targets for neuroprotection in Parkinson&#x02019;s disease</article-title><source>Biochim. Biophys. Acta</source><year>2009</year><volume>1792</volume><fpage>676</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2008.09.009</pub-id><?supplied-pmid 18930814?><pub-id pub-id-type="pmid">18930814</pub-id></element-citation></ref><ref id="B24-ijms-22-04771"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K.J.</given-names></name><name><surname>Lassmann</surname><given-names>H.</given-names></name></person-group><article-title>The role of nitric oxide in multiple sclerosis</article-title><source>Lancet Neurol.</source><year>2002</year><volume>1</volume><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(02)00102-3</pub-id><pub-id pub-id-type="pmid">12849456</pub-id></element-citation></ref><ref id="B25-ijms-22-04771"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Yao</surname><given-names>Z.</given-names></name></person-group><article-title>Insights in pathogenesis of multiple sclerosis: Nitric oxide may induce mitochondrial dysfunction of oligodendrocytes</article-title><source>Rev. Neurosci.</source><year>2018</year><volume>29</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1515/revneuro-2017-0033</pub-id><?supplied-pmid 28822986?><pub-id pub-id-type="pmid">28822986</pub-id></element-citation></ref><ref id="B26-ijms-22-04771"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.Q.</given-names></name><name><surname>Mou</surname><given-names>R.T.</given-names></name><name><surname>Feng</surname><given-names>D.X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name></person-group><article-title>The role of nitric oxide in stroke</article-title><source>Med. Gas Res.</source><year>2017</year><volume>7</volume><fpage>194</fpage><lpage>203</lpage><?supplied-pmid 29152213?><pub-id pub-id-type="pmid">29152213</pub-id></element-citation></ref><ref id="B27-ijms-22-04771"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>J.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><name><surname>Davalos</surname><given-names>A.</given-names></name></person-group><article-title>Nitric oxide-related brain damage in acute ischemic stroke</article-title><source>Stroke</source><year>2000</year><volume>31</volume><fpage>852</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1161/01.STR.31.4.852</pub-id><?supplied-pmid 10753987?><pub-id pub-id-type="pmid">10753987</pub-id></element-citation></ref><ref id="B28-ijms-22-04771"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urushitani</surname><given-names>M.</given-names></name><name><surname>Shimohama</surname><given-names>S.</given-names></name></person-group><article-title>The role of nitric oxide in amyotrophic lateral sclerosis</article-title><source>Amyotroph. Lateral. Scler. Other. Motor. Neuron. Disord.</source><year>2001</year><volume>2</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11675875</pub-id></element-citation></ref><ref id="B29-ijms-22-04771"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yui</surname><given-names>K.</given-names></name><name><surname>Kawasaki</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>H.</given-names></name><name><surname>Ogawa</surname><given-names>S.</given-names></name></person-group><article-title>Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2016</year><volume>15</volume><fpage>587</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.2174/1871527315666160413121751</pub-id><pub-id pub-id-type="pmid">27071787</pub-id></element-citation></ref><ref id="B30-ijms-22-04771"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinert</surname><given-names>J.R.</given-names></name><name><surname>Chernova</surname><given-names>T.</given-names></name><name><surname>Forsythe</surname><given-names>I.D.</given-names></name></person-group><article-title>Nitric oxide signaling in brain function, dysfunction, and dementia</article-title><source>Neuroscientist</source><year>2010</year><volume>16</volume><fpage>435</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1177/1073858410366481</pub-id><pub-id pub-id-type="pmid">20817920</pub-id></element-citation></ref><ref id="B31-ijms-22-04771"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlawat</surname><given-names>A.</given-names></name><name><surname>Rana</surname><given-names>A.</given-names></name><name><surname>Goyal</surname><given-names>N.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group><article-title>Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain</article-title><source>Inflammopharmacology</source><year>2014</year><volume>22</volume><fpage>269</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1007/s10787-014-0213-0</pub-id><pub-id pub-id-type="pmid">25095760</pub-id></element-citation></ref><ref id="B32-ijms-22-04771"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>A.K.</given-names></name><name><surname>Tandan</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Dudhgaonkar</surname><given-names>S.P.</given-names></name></person-group><article-title>Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats</article-title><source>Eur. J. Pharmacol.</source><year>2006</year><volume>530</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2005.11.029</pub-id><pub-id pub-id-type="pmid">16364289</pub-id></element-citation></ref><ref id="B33-ijms-22-04771"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J.</given-names></name><name><surname>Thomsen</surname><given-names>L.L.</given-names></name><name><surname>Iversen</surname><given-names>H.</given-names></name></person-group><article-title>Nitric oxide is a key molecule in migraine and other vascular headaches</article-title><source>Trends Pharmacol. Sci.</source><year>1994</year><volume>15</volume><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/0165-6147(94)90075-2</pub-id><pub-id pub-id-type="pmid">7538702</pub-id></element-citation></ref><ref id="B34-ijms-22-04771"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neeb</surname><given-names>L.</given-names></name><name><surname>Reuter</surname><given-names>U.</given-names></name></person-group><article-title>Nitric oxide in migraine</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2007</year><volume>6</volume><fpage>258</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.2174/187152707781387233</pub-id><pub-id pub-id-type="pmid">17691982</pub-id></element-citation></ref><ref id="B35-ijms-22-04771"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Kuy</surname><given-names>P.H.</given-names></name><name><surname>Lohman</surname><given-names>J.J.</given-names></name></person-group><article-title>The role of nitric oxide in vascular headache</article-title><source>Pharm. World Sci.</source><year>2003</year><volume>25</volume><fpage>146</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1023/A:1024800512790</pub-id><?supplied-pmid 12964492?><pub-id pub-id-type="pmid">12964492</pub-id></element-citation></ref><ref id="B36-ijms-22-04771"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>M.</given-names></name><name><surname>Harandizadeh</surname><given-names>F.</given-names></name><name><surname>Niazmand</surname><given-names>S.</given-names></name><name><surname>Soukhtanloo</surname><given-names>M.</given-names></name><name><surname>Faizpour</surname><given-names>A.</given-names></name><name><surname>Ghasemabady</surname><given-names>M.</given-names></name></person-group><article-title>The role for nitric oxide on the effects of hydroalcoholic extract of Achillea wilhelmsii on seizure</article-title><source>Avic. J. Phytomed.</source><year>2014</year><volume>4</volume><fpage>251</fpage><lpage>259</lpage></element-citation></ref><ref id="B37-ijms-22-04771"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faradji</surname><given-names>H.</given-names></name><name><surname>Rousset</surname><given-names>C.</given-names></name><name><surname>Debilly</surname><given-names>G.</given-names></name><name><surname>Vergnes</surname><given-names>M.</given-names></name><name><surname>Cespuglio</surname><given-names>R.</given-names></name></person-group><article-title>Sleep and epilepsy: A key role for nitric oxide?</article-title><source>Epilepsia</source><year>2000</year><volume>41</volume><fpage>794</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb00245.x</pub-id><pub-id pub-id-type="pmid">10897149</pub-id></element-citation></ref><ref id="B38-ijms-22-04771"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Zochodne</surname><given-names>D.W.</given-names></name></person-group><article-title>NO pain: Potential roles of nitric oxide in neuropathic pain</article-title><source>Pain Pract.</source><year>2004</year><volume>4</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1111/j.1533-2500.2004.04002.x</pub-id><pub-id pub-id-type="pmid">17129298</pub-id></element-citation></ref><ref id="B39-ijms-22-04771"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>S.S.</given-names></name></person-group><article-title>Role of nitric oxide in diabetic nephropathy</article-title><source>Semin. Nephrol.</source><year>2004</year><volume>24</volume><fpage>333</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.semnephrol.2004.04.005</pub-id><pub-id pub-id-type="pmid">15252773</pub-id></element-citation></ref><ref id="B40-ijms-22-04771"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Kern</surname><given-names>T.S.</given-names></name></person-group><article-title>Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy</article-title><source>Front. Biosci.</source><year>2009</year><volume>14</volume><fpage>3974</fpage><lpage>3987</lpage><pub-id pub-id-type="doi">10.2741/3505</pub-id></element-citation></ref><ref id="B41-ijms-22-04771"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torre</surname><given-names>D.</given-names></name><name><surname>Pugliese</surname><given-names>A.</given-names></name><name><surname>Speranza</surname><given-names>F.</given-names></name></person-group><article-title>Role of nitric oxide in HIV-1 infection: Friend or foe?</article-title><source>Lancet Infect. Dis.</source><year>2002</year><volume>2</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(02)00262-1</pub-id><pub-id pub-id-type="pmid">12062993</pub-id></element-citation></ref><ref id="B42-ijms-22-04771"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Jana</surname><given-names>M.</given-names></name><name><surname>Dasgupta</surname><given-names>S.</given-names></name><name><surname>Koka</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Wood</surname><given-names>C.</given-names></name><name><surname>Pahan</surname><given-names>K.</given-names></name></person-group><article-title>Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>39312</fpage><lpage>39319</lpage><pub-id pub-id-type="doi">10.1074/jbc.M205107200</pub-id><?supplied-pmid 12167619?><pub-id pub-id-type="pmid">12167619</pub-id></element-citation></ref><ref id="B43-ijms-22-04771"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>K.P.</given-names></name><name><surname>Vavrin</surname><given-names>Z.</given-names></name><name><surname>Eichwald</surname><given-names>E.</given-names></name><name><surname>Hibbs</surname><given-names>J.B.</given-names><suffix>Jr.</suffix></name><name><surname>Weis</surname><given-names>J.J.</given-names></name></person-group><article-title>Nitric oxide production during murine Lyme disease: Lack of involvement in host resistance or pathology</article-title><source>Infect. Immun.</source><year>1995</year><volume>63</volume><fpage>3886</fpage><lpage>3895</lpage><pub-id pub-id-type="doi">10.1128/IAI.63.10.3886-3895.1995</pub-id><?supplied-pmid 7558296?><pub-id pub-id-type="pmid">7558296</pub-id></element-citation></ref><ref id="B44-ijms-22-04771"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brundin</surname><given-names>L.</given-names></name><name><surname>Svenungsson</surname><given-names>E.</given-names></name><name><surname>Morcos</surname><given-names>E.</given-names></name><name><surname>Andersson</surname><given-names>M.</given-names></name><name><surname>Olsson</surname><given-names>T.</given-names></name><name><surname>Lundberg</surname><given-names>I.</given-names></name><name><surname>Wiklund</surname><given-names>N.P.</given-names></name></person-group><article-title>Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus</article-title><source>Ann. Neurol.</source><year>1998</year><volume>44</volume><fpage>704</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1002/ana.410440421</pub-id><pub-id pub-id-type="pmid">9778274</pub-id></element-citation></ref><ref id="B45-ijms-22-04771"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>E.K.</given-names></name><name><surname>Kim</surname><given-names>J.W.</given-names></name><name><surname>Kang</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Hua</surname><given-names>Q.H.</given-names></name><name><surname>Park</surname><given-names>T.I.</given-names></name><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Sohn</surname><given-names>Y.K.</given-names></name></person-group><article-title>The role of inducible nitric oxide synthase following spinal cord injury in rat</article-title><source>J. Korean Med. Sci.</source><year>2005</year><volume>20</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.3346/jkms.2005.20.4.663</pub-id><pub-id pub-id-type="pmid">16100462</pub-id></element-citation></ref><ref id="B46-ijms-22-04771"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardivo</surname><given-names>V.</given-names></name><name><surname>Crobeddu</surname><given-names>E.</given-names></name><name><surname>Pilloni</surname><given-names>G.</given-names></name><name><surname>Fontanella</surname><given-names>M.</given-names></name><name><surname>Spena</surname><given-names>G.</given-names></name><name><surname>Panciani</surname><given-names>P.P.</given-names></name><name><surname>Berjano</surname><given-names>P.</given-names></name><name><surname>Ajello</surname><given-names>M.</given-names></name><name><surname>Bozzaro</surname><given-names>M.</given-names></name><name><surname>Agnoletti</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Say &#x0201c;no&#x0201d; to spinal cord injury: Is nitric oxide an option for therapeutic strategies?</article-title><source>Int. J. Neurosci.</source><year>2015</year><volume>125</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.3109/00207454.2014.908877</pub-id><?supplied-pmid 24697508?><pub-id pub-id-type="pmid">24697508</pub-id></element-citation></ref><ref id="B47-ijms-22-04771"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>N.D.</given-names></name></person-group><article-title>Potential risks of nitric oxide inhibition in spinal cord injury</article-title><source>J. Spinal. Cord Med.</source><year>2007</year><volume>30</volume><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/10790268.2007.11753906</pub-id><pub-id pub-id-type="pmid">17385264</pub-id></element-citation></ref><ref id="B48-ijms-22-04771"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E.-J.</given-names></name><name><surname>Choi</surname><given-names>M.-J.</given-names></name><name><surname>Lee</surname><given-names>G.</given-names></name><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name><name><surname>Kim</surname><given-names>H.-S.</given-names></name></person-group><article-title>Regulation of neuroinflammation by matrix metalloproteinase-8 inhibitor derivatives in activated microglia and astrocytes</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>78677</fpage><lpage>78690</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.20207</pub-id><pub-id pub-id-type="pmid">29108257</pub-id></element-citation></ref><ref id="B49-ijms-22-04771"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Huo</surname><given-names>J.</given-names></name><name><surname>Bao</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name></person-group><article-title>6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-gamma</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>42001</fpage><lpage>42006</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.16719</pub-id><?supplied-pmid 28410218?><pub-id pub-id-type="pmid">28410218</pub-id></element-citation></ref><ref id="B50-ijms-22-04771"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>D.S.</given-names></name><name><surname>Qui</surname><given-names>M.</given-names></name><name><surname>Krishnaswamy</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Stone</surname><given-names>W.</given-names></name></person-group><article-title>Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines</article-title><source>Nitric Oxide</source><year>2003</year><volume>8</volume><fpage>127</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/S1089-8603(02)00148-9</pub-id><pub-id pub-id-type="pmid">12620376</pub-id></element-citation></ref><ref id="B51-ijms-22-04771"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>T.</given-names></name><name><surname>Sershen</surname><given-names>C.L.</given-names></name><name><surname>May</surname><given-names>E.E.</given-names></name></person-group><article-title>Investigating the Role of TNF-alpha and IFN-gamma Activation on the Dynamics of iNOS Gene Expression in LPS Stimulated Macrophages</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0153289</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0153289</pub-id><?supplied-pmid 27276061?><pub-id pub-id-type="pmid">27276061</pub-id></element-citation></ref><ref id="B52-ijms-22-04771"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>R.</given-names></name><name><surname>Xapelli</surname><given-names>S.</given-names></name><name><surname>Santos</surname><given-names>T.</given-names></name><name><surname>Silva</surname><given-names>A.P.</given-names></name><name><surname>Cristovao</surname><given-names>A.</given-names></name><name><surname>Cortes</surname><given-names>L.</given-names></name><name><surname>Malva</surname><given-names>J.O.</given-names></name></person-group><article-title>Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>41921</fpage><lpage>41934</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.164020</pub-id><?supplied-pmid 20959451?><pub-id pub-id-type="pmid">20959451</pub-id></element-citation></ref><ref id="B53-ijms-22-04771"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Krukoff</surname><given-names>T.L.</given-names></name></person-group><article-title>Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells</article-title><source>Endocrinology</source><year>2004</year><volume>145</volume><fpage>4550</fpage><lpage>4557</lpage><pub-id pub-id-type="doi">10.1210/en.2004-0327</pub-id><?supplied-pmid 15242984?><pub-id pub-id-type="pmid">15242984</pub-id></element-citation></ref><ref id="B54-ijms-22-04771"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>S.H.</given-names></name><name><surname>Ryu</surname><given-names>G.R.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Ahn</surname><given-names>Y.B.</given-names></name><name><surname>Yoon</surname><given-names>K.H.</given-names></name><name><surname>Kaneto</surname><given-names>H.</given-names></name><name><surname>Ha</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Song</surname><given-names>K.H.</given-names></name></person-group><article-title>Inducible nitric oxide synthase-nitric oxide plays an important role in acute and severe hypoxic injury to pancreatic beta cells</article-title><source>Transplantation</source><year>2008</year><volume>85</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e31816168f9</pub-id><?supplied-pmid 18301327?><pub-id pub-id-type="pmid">18301327</pub-id></element-citation></ref><ref id="B55-ijms-22-04771"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyadjieva</surname><given-names>N.I.</given-names></name><name><surname>Sarkar</surname><given-names>D.K.</given-names></name></person-group><article-title>Microglia play a role in ethanol-induced oxidative stress and apoptosis in developing hypothalamic neurons</article-title><source>Alcohol Clin. Exp. Res.</source><year>2013</year><volume>37</volume><fpage>252</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1530-0277.2012.01889.x</pub-id><pub-id pub-id-type="pmid">22823548</pub-id></element-citation></ref><ref id="B56-ijms-22-04771"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Sulforaphane Inhibits MGO-AGE-Mediated Neuroinflammation by Suppressing NF-&#x003ba;B, MAPK, and AGE&#x02013;RAGE Signaling Pathways in Microglial Cells</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>792</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9090792</pub-id></element-citation></ref><ref id="B57-ijms-22-04771"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S.Y.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>A New Neolignan Derivative, Balanophonin Isolated from Firmiana simplex Delays the Progress of Neuronal Cell Death by Inhibiting Microglial Activation</article-title><source>Biomol. Ther.</source><year>2017</year><volume>25</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2016.224</pub-id><?supplied-pmid 28554197?><pub-id pub-id-type="pmid">28554197</pub-id></element-citation></ref><ref id="B58-ijms-22-04771"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Lignan Glycosides from the Twigs of Chaenomeles sinensis and Their Biological Activities</article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>1174</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00090</pub-id><pub-id pub-id-type="pmid">25894905</pub-id></element-citation></ref><ref id="B59-ijms-22-04771"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>J.</given-names></name><name><surname>Bui</surname><given-names>V.B.</given-names></name><name><surname>Liu</surname><given-names>X.H.</given-names></name><name><surname>Hong</surname><given-names>Z.L.</given-names></name><name><surname>Yang</surname><given-names>G.X.</given-names></name><name><surname>Hu</surname><given-names>J.F.</given-names></name></person-group><article-title>Lignans from the stems of Clematis armandii (&#x0201c;Chuan-Mu-Tong&#x0201d;) and their anti-neuroinflammatory activities</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>153</volume><fpage>737</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.03.036</pub-id><pub-id pub-id-type="pmid">24661966</pub-id></element-citation></ref><ref id="B60-ijms-22-04771"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>L.L.</given-names></name><name><surname>Zhang</surname><given-names>Q.Y.</given-names></name><name><surname>Luo</surname><given-names>X.L.</given-names></name><name><surname>Xiong</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>S.Y.</given-names></name><name><surname>Hu</surname><given-names>J.F.</given-names></name><name><surname>Liu</surname><given-names>X.H.</given-names></name></person-group><article-title>(7R,8S)-9-acetyl-dehydrodiconiferyl alcohol inhibits inflammation and migration in lipopolysaccharide-stimulated macrophages</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.02.018</pub-id><pub-id pub-id-type="pmid">27064013</pub-id></element-citation></ref><ref id="B61-ijms-22-04771"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>Y.F.</given-names></name><name><surname>Su</surname><given-names>X.Q.</given-names></name><name><surname>Li</surname><given-names>M.M.</given-names></name><name><surname>Huo</surname><given-names>H.X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zeng</surname><given-names>K.W.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>Y.F.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Anti-inflammatory lignanamides from the roots of <italic>Solanum melongena</italic> L</article-title><source>Fitoterapia</source><year>2014</year><volume>98</volume><fpage>110</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.07.012</pub-id><pub-id pub-id-type="pmid">25068200</pub-id></element-citation></ref><ref id="B62-ijms-22-04771"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dat</surname><given-names>L.D.</given-names></name><name><surname>Zhao</surname><given-names>B.T.</given-names></name><name><surname>Hung</surname><given-names>N.D.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Min</surname><given-names>B.S.</given-names></name><name><surname>Woo</surname><given-names>M.H.</given-names></name></person-group><article-title>Lignan derivatives from Selaginella tamariscina and their nitric oxide inhibitory effects in LPS-stimulated RAW 264.7 cells</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2017</year><volume>27</volume><fpage>524</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.12.028</pub-id><?supplied-pmid 28038832?><pub-id pub-id-type="pmid">28038832</pub-id></element-citation></ref><ref id="B63-ijms-22-04771"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Iridoid Glycosides from the Twigs of Sambucus williamsii var. coreana and Their Biological Activities</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>2502</fpage><lpage>2508</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00410</pub-id><?supplied-pmid 28841320?><pub-id pub-id-type="pmid">28841320</pub-id></element-citation></ref><ref id="B64-ijms-22-04771"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.W.</given-names></name><name><surname>Quang</surname><given-names>T.H.</given-names></name><name><surname>Ko</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>D.C.</given-names></name><name><surname>Yoon</surname><given-names>C.S.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name></person-group><article-title>Anti-neuroinflammatory effects of cudraflavanone A isolated from the chloroform fraction of Cudrania tricuspidata root bark</article-title><source>Pharm. Biol.</source><year>2018</year><volume>56</volume><fpage>192</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1080/13880209.2018.1447972</pub-id><pub-id pub-id-type="pmid">29521141</pub-id></element-citation></ref><ref id="B65-ijms-22-04771"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Ji</surname><given-names>E.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Yeo</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Equol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In Vitro</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>207</elocation-id><pub-id pub-id-type="doi">10.3390/nu9030207</pub-id><?supplied-pmid 28264445?><pub-id pub-id-type="pmid">28264445</pub-id></element-citation></ref><ref id="B66-ijms-22-04771"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinta</surname><given-names>S.J.</given-names></name><name><surname>Ganesan</surname><given-names>A.</given-names></name><name><surname>Reis-Rodrigues</surname><given-names>P.</given-names></name><name><surname>Lithgow</surname><given-names>G.J.</given-names></name><name><surname>Andersen</surname><given-names>J.K.</given-names></name></person-group><article-title>Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: Implications for Parkinson&#x02019;s disease</article-title><source>Neurotox. Res.</source><year>2013</year><volume>23</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1007/s12640-012-9328-5</pub-id><pub-id pub-id-type="pmid">22573480</pub-id></element-citation></ref><ref id="B67-ijms-22-04771"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scuro</surname><given-names>L.S.</given-names></name><name><surname>Simioni</surname><given-names>P.U.</given-names></name><name><surname>Grabriel</surname><given-names>D.L.</given-names></name><name><surname>Saviani</surname><given-names>E.E.</given-names></name><name><surname>Modolo</surname><given-names>L.V.</given-names></name><name><surname>Tamashiro</surname><given-names>W.M.</given-names></name><name><surname>Salgado</surname><given-names>I.</given-names></name></person-group><article-title>Suppression of nitric oxide production in mouse macrophages by soybean flavonoids accumulated in response to nitroprusside and fungal elicitation</article-title><source>BMC Biochem.</source><year>2004</year><volume>5</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2091-5-5</pub-id><pub-id pub-id-type="pmid">15102332</pub-id></element-citation></ref><ref id="B68-ijms-22-04771"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapkota</surname><given-names>A.</given-names></name><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Cho</surname><given-names>K.S.</given-names></name><name><surname>Jeon</surname><given-names>S.J.</given-names></name><name><surname>Kwon</surname><given-names>O.W.</given-names></name><name><surname>Jang</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Ryu</surname><given-names>J.H.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name></person-group><article-title>Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0171479</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0171479</pub-id><pub-id pub-id-type="pmid">28178289</pub-id></element-citation></ref><ref id="B69-ijms-22-04771"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name></person-group><article-title>Genistein suppresses LPS-induced inflammatory response through inhibiting NF-kappaB following AMP kinase activation in RAW 264.7 macrophages</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e53101</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053101</pub-id><pub-id pub-id-type="pmid">23300870</pub-id></element-citation></ref><ref id="B70-ijms-22-04771"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Moon</surname><given-names>E.</given-names></name><name><surname>Cha</surname><given-names>J.M.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Antineuroinflammatory and Antiproliferative Activities of Constituents from Tilia amurensis</article-title><source>Chem. Pharm. Bull.</source><year>2015</year><volume>63</volume><fpage>837</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1248/cpb.c15-00393</pub-id></element-citation></ref><ref id="B71-ijms-22-04771"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Bae</surname><given-names>M.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Choi</surname><given-names>S.Z.</given-names></name><name><surname>Son</surname><given-names>M.W.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Oh</surname><given-names>D.C.</given-names></name><etal/></person-group><article-title>Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00981</pub-id><?supplied-pmid 28165740?><pub-id pub-id-type="pmid">28165740</pub-id></element-citation></ref><ref id="B72-ijms-22-04771"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wan</surname><given-names>C.X.</given-names></name><name><surname>Xia</surname><given-names>Y.Z.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>M.H.</given-names></name><name><surname>Wang</surname><given-names>Z.D.</given-names></name><name><surname>Li</surname><given-names>Z.R.</given-names></name><name><surname>Li</surname><given-names>X.M.</given-names></name><name><surname>Geng</surname><given-names>Y.D.</given-names></name><etal/></person-group><article-title>Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>1629</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.10.007</pub-id><?supplied-pmid 27823627?><pub-id pub-id-type="pmid">27823627</pub-id></element-citation></ref><ref id="B73-ijms-22-04771"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Jiao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Kuang</surname><given-names>H.</given-names></name></person-group><article-title>Tangeretin exerts anti-neuroinflammatory effects via NF-kappaB modulation in lipopolysaccharide-stimulated microglial cells</article-title><source>Int. Immunopharmacol.</source><year>2014</year><volume>19</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.01.011</pub-id><?supplied-pmid 24462494?><pub-id pub-id-type="pmid">24462494</pub-id></element-citation></ref><ref id="B74-ijms-22-04771"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Moon</surname><given-names>E.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Pang</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Identification of cytotoxic and anti-inflammatory constituents from the bark of Toxicodendron vernicifluum (Stokes) F.A. Barkley</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>162</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.12.071</pub-id><pub-id pub-id-type="pmid">25582488</pub-id></element-citation></ref><ref id="B75-ijms-22-04771"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>K.W.</given-names></name><name><surname>Moon</surname><given-names>E.</given-names></name><name><surname>Kwon</surname><given-names>O.W.</given-names></name><name><surname>Lee</surname><given-names>S.O.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.Z.</given-names></name><name><surname>Son</surname><given-names>M.W.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Anti-neuroinflammatory diarylheptanoids from the rhizomes of Dioscorea nipponica</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2013</year><volume>23</volume><fpage>3806</fpage><lpage>3809</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.04.073</pub-id><pub-id pub-id-type="pmid">23707257</pub-id></element-citation></ref><ref id="B76-ijms-22-04771"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>S.C.</given-names></name><name><surname>Chang</surname><given-names>K.S.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name></person-group><article-title>Anti-neuroinflammatory capacity of fresh ginger is attributed mainly to 10-gingerol</article-title><source>Food Chem.</source><year>2013</year><volume>141</volume><fpage>3183</fpage><lpage>3191</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.06.010</pub-id><?supplied-pmid 23871076?><pub-id pub-id-type="pmid">23871076</pub-id></element-citation></ref><ref id="B77-ijms-22-04771"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Min</surname><given-names>J.S.</given-names></name><name><surname>Chae</surname><given-names>U.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Song</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>S.R.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name></person-group><article-title>Anti-inflammatory effect of oleuropein on microglia through regulation of Drp1-dependent mitochondrial fission</article-title><source>J. Neuroimmunol.</source><year>2017</year><volume>306</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2017.02.019</pub-id><?supplied-pmid 28385187?><pub-id pub-id-type="pmid">28385187</pub-id></element-citation></ref><ref id="B78-ijms-22-04771"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Kwon</surname><given-names>O.W.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Chun</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Shin</surname><given-names>D.Y.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name></person-group><article-title>Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0120203</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0120203</pub-id><pub-id pub-id-type="pmid">25789481</pub-id></element-citation></ref><ref id="B79-ijms-22-04771"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Park</surname><given-names>K.J.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Salicin derivatives from Salix glandulosa and their biological activities</article-title><source>Fitoterapia</source><year>2015</year><volume>106</volume><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2015.08.013</pub-id><?supplied-pmid 26344424?><pub-id pub-id-type="pmid">26344424</pub-id></element-citation></ref><ref id="B80-ijms-22-04771"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azam</surname><given-names>F.</given-names></name><name><surname>Amer</surname><given-names>A.M.</given-names></name><name><surname>Abulifa</surname><given-names>A.R.</given-names></name><name><surname>Elzwawi</surname><given-names>M.M.</given-names></name></person-group><article-title>Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer&#x02019;s drugs: A computational investigation</article-title><source>Drug Des. Devel. Ther.</source><year>2014</year><volume>8</volume><fpage>2045</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S67778</pub-id></element-citation></ref><ref id="B81-ijms-22-04771"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruangsuriya</surname><given-names>J.</given-names></name><name><surname>Budprom</surname><given-names>P.</given-names></name><name><surname>Viriyakhasem</surname><given-names>N.</given-names></name><name><surname>Kongdang</surname><given-names>P.</given-names></name><name><surname>Chokchaitaweesuk</surname><given-names>C.</given-names></name><name><surname>Sirikaew</surname><given-names>N.</given-names></name><name><surname>Chomdej</surname><given-names>S.</given-names></name><name><surname>Nganvongpanit</surname><given-names>K.</given-names></name><name><surname>Ongchai</surname><given-names>S.</given-names></name></person-group><article-title>Suppression of Cartilage Degradation by Zingerone Involving the p38 and JNK MAPK Signaling Pathway</article-title><source>Planta Med.</source><year>2017</year><volume>83</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1055/s-0042-113387</pub-id><?supplied-pmid 27574898?><pub-id pub-id-type="pmid">27574898</pub-id></element-citation></ref><ref id="B82-ijms-22-04771"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>H.J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Ding</surname><given-names>H.</given-names></name><name><surname>Lv</surname><given-names>Q.</given-names></name><name><surname>Hou</surname><given-names>S.K.</given-names></name></person-group><article-title>Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway</article-title><source>Eur. J. Pharmacol.</source><year>2016</year><volume>772</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.12.027</pub-id><pub-id pub-id-type="pmid">26698392</pub-id></element-citation></ref><ref id="B83-ijms-22-04771"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>R.</given-names></name><name><surname>Gunawardena</surname><given-names>D.</given-names></name><name><surname>Ahktar</surname><given-names>M.A.</given-names></name><name><surname>Low</surname><given-names>M.</given-names></name><name><surname>Reddell</surname><given-names>P.</given-names></name><name><surname>Munch</surname><given-names>G.</given-names></name></person-group><article-title>Anti-Inflammatory Chemical Profiling of the Australian Rainforest Tree Alphitonia petriei (Rhamnaceae)</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1521</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21111521</pub-id></element-citation></ref><ref id="B84-ijms-22-04771"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesaik</surname><given-names>A.M.</given-names></name><name><surname>Poh</surname><given-names>H.W.</given-names></name><name><surname>Bin</surname><given-names>O.Y.</given-names></name><name><surname>Elawad</surname><given-names>I.</given-names></name><name><surname>Alsayed</surname><given-names>B.</given-names></name></person-group><article-title>In Vivo Anti-Inflammatory, Anti-Bacterial and Anti-Diarrhoeal Activity of Ziziphus Jujuba Fruit Extract</article-title><source>Open Access Maced. J. Med. Sci.</source><year>2018</year><volume>6</volume><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.3889/oamjms.2018.168</pub-id><?supplied-pmid 29875842?><pub-id pub-id-type="pmid">29875842</pub-id></element-citation></ref><ref id="B85-ijms-22-04771"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>D.C.</given-names></name><name><surname>Yoon</surname><given-names>C.S.</given-names></name><name><surname>Ko</surname><given-names>W.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name></person-group><article-title>Anti-Inflammatory Effects and Mechanisms of Action of Coussaric and Betulinic Acids Isolated from Diospyros kaki in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1206</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21091206</pub-id></element-citation></ref><ref id="B86-ijms-22-04771"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.J.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Bioactive triterpenoids from twigs of Betula schmidtii</article-title><source>Bioorg. Chem.</source><year>2018</year><volume>77</volume><fpage>527</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2018.02.006</pub-id><?supplied-pmid 29454829?><pub-id pub-id-type="pmid">29454829</pub-id></element-citation></ref><ref id="B87-ijms-22-04771"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.S.</given-names></name><name><surname>Baek</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>H.B.</given-names></name><name><surname>Moon</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name></person-group><article-title>A new rearranged eudesmane sesquiterpene and bioactive sesquiterpenes from the twigs of Lindera glauca (Sieb. et Zucc.) Blume</article-title><source>Arch. Pharm. Res.</source><year>2016</year><volume>39</volume><fpage>1628</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1007/s12272-016-0838-1</pub-id><pub-id pub-id-type="pmid">27620498</pub-id></element-citation></ref><ref id="B88-ijms-22-04771"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Park</surname><given-names>K.J.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>A biphenyl derivative from the twigs of Chaenomeles speciosa</article-title><source>Bioorg. Chem.</source><year>2017</year><volume>72</volume><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2017.04.003</pub-id><pub-id pub-id-type="pmid">28460357</pub-id></element-citation></ref><ref id="B89-ijms-22-04771"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Holophyllane A: A Triterpenoid Possessing an Unprecedented B-nor-3,4-seco-17,14-friedo-lanostane Architecture from Abies holophylla</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><pub-id pub-id-type="doi">10.1038/srep43646</pub-id></element-citation></ref><ref id="B90-ijms-22-04771"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiem</surname><given-names>P.V.</given-names></name><name><surname>Huyen</surname><given-names>L.T.</given-names></name><name><surname>Hang</surname><given-names>D.T.</given-names></name><name><surname>Nhiem</surname><given-names>N.X.</given-names></name><name><surname>Tai</surname><given-names>B.H.</given-names></name><name><surname>Anh</surname><given-names>H.L.</given-names></name><name><surname>Cuong</surname><given-names>P.V.</given-names></name><name><surname>Quang</surname><given-names>T.H.</given-names></name><name><surname>Minh</surname><given-names>C.V.</given-names></name><name><surname>Dau</surname><given-names>N.V.</given-names></name><etal/></person-group><article-title>Sesquiterpene derivatives from marine sponge Smenospongia cerebriformis and their anti-inflammatory activity</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2017</year><volume>27</volume><fpage>1525</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.02.040</pub-id><pub-id pub-id-type="pmid">28262525</pub-id></element-citation></ref><ref id="B91-ijms-22-04771"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>W.H.</given-names></name><name><surname>Lim</surname><given-names>Y.M.</given-names></name></person-group><article-title>Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation</article-title><source>Biochem. Res. Int.</source><year>2015</year><volume>2015</volume><pub-id pub-id-type="doi">10.1155/2015/279356</pub-id><?supplied-pmid 26491566?><pub-id pub-id-type="pmid">26491566</pub-id></element-citation></ref><ref id="B92-ijms-22-04771"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>W.H.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Piao</surname><given-names>Y.</given-names></name><name><surname>Pak</surname><given-names>C.J.</given-names></name><name><surname>Oh</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>M.S.</given-names></name><name><surname>Pak</surname><given-names>Y.K.</given-names></name></person-group><article-title>Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-kappaB</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>174</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.07.039</pub-id><?supplied-pmid 26231448?><pub-id pub-id-type="pmid">26231448</pub-id></element-citation></ref><ref id="B93-ijms-22-04771"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>K.W.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Tu</surname><given-names>P.F.</given-names></name></person-group><article-title>Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-kappaB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>298</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.08.016</pub-id><?supplied-pmid 24055519?><pub-id pub-id-type="pmid">24055519</pub-id></element-citation></ref><ref id="B94-ijms-22-04771"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nhiem</surname><given-names>N.X.</given-names></name><name><surname>Tuong</surname><given-names>N.T.</given-names></name><name><surname>Ky</surname><given-names>P.T.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Ngoc</surname><given-names>T.M.</given-names></name><name><surname>Yen</surname><given-names>P.H.</given-names></name><name><surname>Tai</surname><given-names>B.H.</given-names></name><name><surname>Quang</surname><given-names>T.H.</given-names></name><name><surname>Kiem</surname><given-names>P.V.</given-names></name><etal/></person-group><article-title>Chemical Components from Phaeanthus vietnamensis and Their Inhibitory NO Production in BV2 Cells</article-title><source>Chem. Biodivers.</source><year>2017</year><volume>14</volume><pub-id pub-id-type="doi">10.1002/cbdv.201700013</pub-id><?supplied-pmid 28323398?><pub-id pub-id-type="pmid">28323398</pub-id></element-citation></ref><ref id="B95-ijms-22-04771"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>K.S.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name></person-group><article-title>Phytochemical and pharmacological potential of Medicago sativa: A review</article-title><source>Pharm. Biol.</source><year>2011</year><volume>49</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.3109/13880209.2010.504732</pub-id><pub-id pub-id-type="pmid">20969516</pub-id></element-citation></ref><ref id="B96-ijms-22-04771"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Pi</surname><given-names>H.</given-names></name><name><surname>Ruan</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>Anti-inflammatory activity of omphalocarpin isolated from Radix Toddaliae Asiaticae</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>155</volume><fpage>1553</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.07.055</pub-id><pub-id pub-id-type="pmid">25102246</pub-id></element-citation></ref><ref id="B97-ijms-22-04771"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Yeo</surname><given-names>E.J.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Isolation of bioactive biphenyl compounds from the twigs of Chaenomeles sinensis</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>351</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.12.004</pub-id><pub-id pub-id-type="pmid">26706168</pub-id></element-citation></ref><ref id="B98-ijms-22-04771"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>H.J.</given-names></name><name><surname>Hwang</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>E.S.</given-names></name><name><surname>Hyun</surname><given-names>J.W.</given-names></name><name><surname>Yi</surname><given-names>P.H.</given-names></name><name><surname>Kim</surname><given-names>G.S.</given-names></name><name><surname>Lee</surname><given-names>S.E.</given-names></name><name><surname>Pang</surname><given-names>C.</given-names></name><name><surname>Park</surname><given-names>Y.J.</given-names></name><name><surname>Chung</surname><given-names>K.H.</given-names></name><etal/></person-group><article-title>Anti-inflammatory activity of a new cyclic peptide, citrusin XI, isolated from the fruits of Citrus unshiu</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>163</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.01.024</pub-id><pub-id pub-id-type="pmid">25625351</pub-id></element-citation></ref><ref id="B99-ijms-22-04771"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Gaire</surname><given-names>B.P.</given-names></name><name><surname>Do</surname><given-names>M.H.</given-names></name><name><surname>Lee</surname><given-names>T.H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Anti-neuroinflammatory and neuroprotective effects of the Lindera neesiana fruit in vitro</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>872</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.05.002</pub-id><pub-id pub-id-type="pmid">27288923</pub-id></element-citation></ref><ref id="B100-ijms-22-04771"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Moon</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>4-Methylthio-butanyl derivatives from the seeds of Raphanus sativus and their biological evaluation on anti-inflammatory and antitumor activities</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>151</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.11.003</pub-id><pub-id pub-id-type="pmid">24231071</pub-id></element-citation></ref><ref id="B101-ijms-22-04771"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>G.Y.</given-names></name><name><surname>Cheng</surname><given-names>Y.C.</given-names></name><name><surname>Wang</surname><given-names>K.W.</given-names></name><name><surname>Wang</surname><given-names>X.Y.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name></person-group><article-title>An Unusual Tetrahydrofuran Lignan from the Roots of Zanthoxylum planispinum and the Potential Anti-inflammatory Effects</article-title><source>Chem. Biodivers.</source><year>2017</year><volume>14</volume><pub-id pub-id-type="doi">10.1002/cbdv.201600214</pub-id><?supplied-pmid 27585089?><pub-id pub-id-type="pmid">27585089</pub-id></element-citation></ref><ref id="B102-ijms-22-04771"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.J.</given-names></name><name><surname>Cha</surname><given-names>J.M.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Phenolic constituents from the twigs of Betula schmidtii collected in Goesan, Korea</article-title><source>Phytochemistry</source><year>2019</year><volume>167</volume><pub-id pub-id-type="doi">10.1016/j.phytochem.2019.112085</pub-id></element-citation></ref><ref id="B103-ijms-22-04771"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Cho</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>Y.U.</given-names></name><name><surname>Choi</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Sulforaphane-enriched broccoli sprouts pretreated by pulsed electric fields reduces neuroinflammation and ameliorates scopolamine-induced amnesia in mouse brain through its antioxidant ability via Nrf2-HO-1 activation</article-title><source>Oxid. Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><pub-id pub-id-type="doi">10.1155/2019/3549274</pub-id><?supplied-pmid 31049133?><pub-id pub-id-type="pmid">31049133</pub-id></element-citation></ref><ref id="B104-ijms-22-04771"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Yumnam</surname><given-names>S.</given-names></name><name><surname>Ji</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-&#x003ba;B inhibition and Nrf2/HO-1 activation</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>194</elocation-id><pub-id pub-id-type="doi">10.3390/cells8020194</pub-id></element-citation></ref><ref id="B105-ijms-22-04771"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.M.</given-names></name><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Lee</surname><given-names>T.H.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Phenolic Glycosides from <italic>Capsella bursa-pastoris</italic> (L.) Medik and Their Anti-Inflammatory Activity</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1203</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22061023</pub-id></element-citation></ref><ref id="B106-ijms-22-04771"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1134</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00111</pub-id><?supplied-pmid 28358502?><pub-id pub-id-type="pmid">28358502</pub-id></element-citation></ref><ref id="B107-ijms-22-04771"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>K.W.</given-names></name><name><surname>Park</surname><given-names>J.E.</given-names></name><name><surname>Cha</surname><given-names>J.M.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Three New Lignan Glycosides from the Firmiana simplex</article-title><source>Chem. Pharm. Bull.</source><year>2019</year><volume>67</volume><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1248/cpb.c18-00537</pub-id></element-citation></ref><ref id="B108-ijms-22-04771"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>K.W.</given-names></name><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Phenolic derivatives from the stems of Lagerstroemia indica and their biological activity</article-title><source>Heterocycles</source><year>2015</year><volume>91</volume><fpage>2355</fpage><lpage>2366</lpage></element-citation></ref><ref id="B109-ijms-22-04771"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Lee</surname><given-names>T.H.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Secoiridoid Glycosides from the Twigs of Ligustrum obtusifolium Possess Anti-inflammatory and Neuroprotective Effects</article-title><source>Chem. Pharm. Bull.</source><year>2018</year><volume>66</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1248/cpb.c17-00720</pub-id></element-citation></ref><ref id="B110-ijms-22-04771"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kwon</surname><given-names>O.W.</given-names></name><name><surname>Pak</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title><italic>N</italic>,<italic>N</italic>-disubstituted azines attenuate LPS-mediated neuroinflammation in microglia and neuronal apoptosis via inhibiting MAPK signaling pathways</article-title><source>BMC Neurosci.</source><year>2017</year><volume>18</volume><elocation-id>82</elocation-id><pub-id pub-id-type="doi">10.1186/s12868-017-0399-3</pub-id><pub-id pub-id-type="pmid">29281977</pub-id></element-citation></ref><ref id="B111-ijms-22-04771"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Lan</surname><given-names>X.Y.</given-names></name><name><surname>Xiao</surname><given-names>J.H.</given-names></name><name><surname>Yang</surname><given-names>J.C.</given-names></name><name><surname>Kao</surname><given-names>Y.T.</given-names></name><name><surname>Chang</surname><given-names>S.T.</given-names></name></person-group><article-title>Antiinflammatory activity of Lindera erythrocarpa fruits</article-title><source>Phytotherapy. Res.</source><year>2007</year><volume>22</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1002/ptr.2289</pub-id><?supplied-pmid 17726736?><pub-id pub-id-type="pmid">17726736</pub-id></element-citation></ref><ref id="B112-ijms-22-04771"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.J.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Antineurodegenerative labdane diterpenoid glycosides from the twigs of Pinus koraiensis</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>1794</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01158</pub-id><?supplied-pmid 32520551?><pub-id pub-id-type="pmid">32520551</pub-id></element-citation></ref><ref id="B113-ijms-22-04771"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Two New Phenolic Glycosides from Sorbus commixta</article-title><source>Chem. Pharm. Bull.</source><year>2018</year><volume>66</volume><fpage>839</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1248/cpb.c18-00280</pub-id><?supplied-pmid 30068805?><pub-id pub-id-type="pmid">30068805</pub-id></element-citation></ref><ref id="B114-ijms-22-04771"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Choi</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Neuroprotective Fatty Acids from the Stem Bark of Sorbus commixta</article-title><source>Lipids</source><year>2016</year><volume>51</volume><fpage>989</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1007/s11745-016-4172-7</pub-id><pub-id pub-id-type="pmid">27386872</pub-id></element-citation></ref><ref id="B115-ijms-22-04771"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>H.M.</given-names></name><name><surname>Yu</surname><given-names>J.S.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Ko</surname><given-names>Y.-J.</given-names></name><name><surname>Lee</surname><given-names>I.K.</given-names></name><name><surname>Park</surname><given-names>W.S.</given-names></name><name><surname>Chung</surname><given-names>S.J.</given-names></name><name><surname>Ahn</surname><given-names>M.-J.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Chemical constituents of the root bark of Ulmus davidiana var. japonica and their potential biological activities</article-title><source>Bioorg. Chem.</source><year>2019</year><volume>91</volume><pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103145</pub-id></element-citation></ref><ref id="B116-ijms-22-04771"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Venkatesan</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Neuroprotective and Anti-Inflammatory Activities of Allyl Isothiocyanate through Attenuation of JNK/NF-kappaB/TNF-alpha Signaling</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>1423</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18071423</pub-id></element-citation></ref><ref id="B117-ijms-22-04771"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Lim</surname><given-names>D.</given-names></name><name><surname>Jung</surname><given-names>J.-K.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Seo</surname><given-names>S.-Y.</given-names></name></person-group><article-title>Synthesis and anti-neuroinflammatory activity of N-heterocyclic analogs based on natural biphenyl-neolignan honokiol</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2019</year><volume>29</volume><fpage>329</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2018.11.014</pub-id><pub-id pub-id-type="pmid">30472026</pub-id></element-citation></ref><ref id="B118-ijms-22-04771"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>H.W.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name><name><surname>Zahra</surname><given-names>Z.</given-names></name><name><surname>Farooqi</surname><given-names>M.Q.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Phytochemicals targeting VEGF and VEGF-related multifactors as anticancer therapy</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>350</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8030350</pub-id></element-citation></ref><ref id="B119-ijms-22-04771"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Oh</surname><given-names>B.G.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Phytochemicals: Target-based therapeutic strategies for diabetic retinopathy</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1519</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23071519</pub-id></element-citation></ref><ref id="B120-ijms-22-04771"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy</article-title><source>Phytomedicine</source><year>2018</year><volume>39</volume><fpage>146</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2017.12.018</pub-id><pub-id pub-id-type="pmid">29433676</pub-id></element-citation></ref><ref id="B121-ijms-22-04771"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Farooqi</surname><given-names>M.Q.</given-names></name><name><surname>Kyunn</surname><given-names>W.W.</given-names></name><name><surname>Arshad</surname><given-names>M.</given-names></name></person-group><article-title>Phytochemical screening and content determination of different species of genus Caesalpinia belonging to different origin with antidiabetic activity</article-title><source>Pharm. J.</source><year>2017</year><volume>9</volume><pub-id pub-id-type="doi">10.5530/pj.2017.6.117</pub-id></element-citation></ref><ref id="B122-ijms-22-04771"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Farooq</surname><given-names>M.A.</given-names></name><name><surname>Kyunn</surname><given-names>W.W.</given-names></name></person-group><article-title>A New Oleanane Type Saponin from the Aerial Parts of Nigella sativa with Anti-Oxidant and Anti-Diabetic Potential</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>2171</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25092171</pub-id></element-citation></ref><ref id="B123-ijms-22-04771"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>M.H.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Cho</surname><given-names>K.</given-names></name><name><surname>Kang</surname><given-names>M.C.</given-names></name><name><surname>Subedi</surname><given-names>L.</given-names></name><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Therapeutic potential of Lespedeza bicolor to prevent methylglyoxal-induced glucotoxicity in familiar diabetic nephropathy</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>1138</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8081138</pub-id><?supplied-pmid 31370192?><pub-id pub-id-type="pmid">31370192</pub-id></element-citation></ref><ref id="B124-ijms-22-04771"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>J.-H.</given-names></name><name><surname>Oh</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Trifostigmanoside I, an Active Compound from Sweet Potato, Restores the Activity of MUC2 and Protects the Tight Junctions through PKC&#x003b1;/&#x003b2; to Maintain Intestinal Barrier Function</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>291</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22010291</pub-id><?supplied-pmid 33396633?><pub-id pub-id-type="pmid">33396633</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-22-04771-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Scheme of nitric oxide (NO) synthesis MAPK activation in myeloid or glial cells can trigger NF-&#x003ba;B transcriptional activation, leading to expression of iNOS. iNOS is subsequently transformed to NOS, which in the presence of NADPH converts L-arginine to L-citrulline and free NO radicals. Stimulants such as bradykinin, acetylcholine, histamine, leukotrienes, and platelet-activating factors from neuronal/endothelial cells or other origins can induce expression of eNOS, and nNOS converts L-arginine to free NO radicals through the same oxidation process.</p></caption><graphic xlink:href="ijms-22-04771-g001"/></fig><fig id="ijms-22-04771-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Biological role of NO in pathophysiological conditions. NO-mediated activation of cGMP, PKG, and VASP can cause platelet inhibition while NO-mediated induction of pro-apoptotic proteins such as PARP, AIF, cytochrome C, and cleaved caspase-3 can induce cell death. NO-mediated activation of cGMP, PKG, Rho A, and Rho kinase can alter smooth muscles relaxation. Inhibition of NAD, NADPH, and GSH by NO increases the probability of cell death. Lipid peroxidation caused by NO induces oxidative stress or damage. S-nitrosylation elicited by NO can cause neurotoxicity or neurodegeneration. NO-mediated induction of PKG and calcium signaling causes exitotoxicity and contraction effects. NO is also involved in neutrophil infiltration and endothelial dysfunctions through effects of mitochondrial respiration, through NK cell toxicity, and through activation of the GAPDH-PARP pathway and its functions.</p></caption><graphic xlink:href="ijms-22-04771-g002"/></fig><fig id="ijms-22-04771-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structures of phytochemicals that can inhibit nitrite production. 1. Balanophonin_<italic>Firmiana simplex</italic>; 2. Chaenomiside A_<italic>Chaenomeles Sinensis</italic>; 3. (7R, 8S)-dehydrodiconferyl alcohol_<italic>Clematis armandii</italic>; 4. Melongenamide C &#x00026; 5. cannabisin F_<italic>Solanum melongena</italic>; 6. (2R, 3S) dihydro-2-(3,5-dimethoxy-4-hydroxyphenyl)-7-methoxy-5-acetyl-benzofuran_<italic>Selagginella tamariscina</italic>; 7. Sambucuside_<italic>Sambucus williamsii</italic>; 8. Cudraflavanone A_<italic>Cudrania tricuspidata</italic>; 9. Daidzein _<italic>Glycine Max</italic>; 10. Eupatilin_<italic>Artemisia asiatica</italic>; 11. Genistein _<italic>Pimpinella anisum</italic>; 12. Orobol 4&#x002b9;-O-&#x003b2;- D- apiofuranosyl-(1&#x02192;6)-&#x003b2;-D-glucopyranoside_<italic>Tilia amurensis</italic>; 13. Quercetin_<italic>Impatiens balsamina</italic>; 14. Sophoraflavanone G_<italic>Sophora alopecuroides</italic>; 15. Tangeretin_<italic>Citrus aurantium</italic>.</p></caption><graphic xlink:href="ijms-22-04771-g003"/></fig><fig id="ijms-22-04771-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Structures of phytochemicals that can inhibit nitrite production<italic>:</italic> 16. Butein_<italic>Oxicodendron vernicifluum</italic>; 17. (4E, 6E)-1-(3&#x02032;,4-dihydroxyphenyl)-7-(4&#x02033;-hydroxyphenyl)-hepta-4,6-dien-3-one &#x00026; 18. Tsaokarylone_<italic>Dioscorea nipponica</italic>; 19. Gingerol_<italic>Zingiber officinale</italic>; 20. Oleuropein_<italic>Fraxinus rhynchophylla</italic>; 21. Paradol_<italic>Zingiber officinale</italic>; 22. Salicortin_<italic>Salix glandulosa</italic>; 23. Shogaol &#x00026; 24. Zingerone_ <italic>Zingiber officinale</italic>; 25. Alphitolic acid_<italic>Ziziphus jajuba</italic>; 26. Betulinic acid &#x00026; 27. Coussaric acid_ <italic>Diospyros Kaki</italic>; 28. Corosolic acid &#x00026; 29. Ambradiolic acid_ <italic>Betula schmidtii</italic>; 30. 23-hydroxybetulinic acid_<italic>Chaenomeles speciose</italic>.</p></caption><graphic xlink:href="ijms-22-04771-g004"/></fig><fig id="ijms-22-04771-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Structures of phytochemicals that can inhibit nitrite production. 31. Holophyllane A_<italic>Abies holophylla</italic>; 32. Ilimaquinone_<italic>Smenospongia cerebriformis</italic>; 33. Masilinic acid_<italic>Olea euroopaea</italic>; 34. Saikosaponins_<italic>Bupleurum falcatum</italic>; 35. Sesquiterpene dimer_<italic>Artemisia argyi</italic> 36. Spathulenol_<italic>Phaeanthus veitnamensis</italic>; 37. Coumestrol_<italic>Medicago sativa Linn</italic>; 38. Omphalocarpin_<italic>Toddaliae Asiaticae</italic>; 39. Aucuparin &#x00026; 40. Dihydrometosolic acid_<italic>Chaenomeles speciose</italic>; 41. &#x003b5;-Cotonefuran_<italic>Chaenomeles Sinensis</italic>; 42. Citrusin XI_<italic>Citrus unshiu</italic>; 43. Koaburaside_<italic>Lindera neesiana</italic>; 44. Sinapoyl desulfoglucoraphenin_<italic>Raphanus sativus</italic>; 45. Zanthplanispine_<italic>Zanthoxylum schinifolium;</italic> 46. (+)-Faurinone_<italic>Lindera glauca</italic>.</p></caption><graphic xlink:href="ijms-22-04771-g005"/></fig><table-wrap id="ijms-22-04771-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-22-04771-t003_Table 3</object-id><label>Table 3</label><caption><p>Potent NO inhibitors with higher potential to inhibit NO production in LPS-activated microglia with lower IC50 than the positive control named as L-NMMA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Potential NO Inhibitor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC50 (&#x003bc;M)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.</td><td align="center" valign="middle" rowspan="1" colspan="1">Sambucasinol B</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.</td><td align="center" valign="middle" rowspan="1" colspan="1">Erythro-(7S,8R)-Guaiacylglycerol-&#x003b2;-coniferyl aldehyde ether</td><td align="center" valign="middle" rowspan="1" colspan="1">0.925</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3.</td><td align="center" valign="middle" rowspan="1" colspan="1">Threo-(7R,8R)-Guaiacylglycerol-&#x003b2;-coniferyl aldehyde ether</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4.</td><td align="center" valign="middle" rowspan="1" colspan="1">sambucuside E</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5.</td><td align="center" valign="middle" rowspan="1" colspan="1">sambucuside C</td><td align="center" valign="middle" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">6.</td><td align="center" valign="middle" rowspan="1" colspan="1">Betulinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">2.38</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7.</td><td align="center" valign="middle" rowspan="1" colspan="1">Equol</td><td align="center" valign="middle" rowspan="1" colspan="1">3.45</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">8.</td><td align="center" valign="middle" rowspan="1" colspan="1">(+)-faurinone</td><td align="center" valign="middle" rowspan="1" colspan="1">3.67</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">9.</td><td align="center" valign="middle" rowspan="1" colspan="1">Maslinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">4.46</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">10.</td><td align="center" valign="middle" rowspan="1" colspan="1">2&#x003b1;-O-benzoyl-3&#x003b2;,19&#x003b1;-dihydroxy-urs-12-en-28-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">4.92</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">11.</td><td align="center" valign="middle" rowspan="1" colspan="1">Obtusifolisides B</td><td align="center" valign="middle" rowspan="1" colspan="1">5.45</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">12.</td><td align="center" valign="middle" rowspan="1" colspan="1">23-hydroxybetulinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">13.</td><td align="center" valign="middle" rowspan="1" colspan="1">Sulforaphane</td><td align="center" valign="middle" rowspan="1" colspan="1">5.85</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">14.</td><td align="center" valign="middle" rowspan="1" colspan="1">Sambucasinol A</td><td align="center" valign="middle" rowspan="1" colspan="1">6.82</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">15.</td><td align="center" valign="middle" rowspan="1" colspan="1">1-cinnamoyltrichilinin</td><td align="center" valign="middle" rowspan="1" colspan="1">7.73</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">16.</td><td align="center" valign="middle" rowspan="1" colspan="1">Morolic acid 3-O-caffeate</td><td align="center" valign="middle" rowspan="1" colspan="1">8.62</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">17.</td><td align="center" valign="middle" rowspan="1" colspan="1">kaempferol</td><td align="center" valign="middle" rowspan="1" colspan="1">8.86</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">18.</td><td align="center" valign="middle" rowspan="1" colspan="1">Erythro-syringylglycerol-8-O-4&#x02032;-coniferyl alcohol ether</td><td align="center" valign="middle" rowspan="1" colspan="1">9.14</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">19.</td><td align="center" valign="middle" rowspan="1" colspan="1">2&#x003b1;-O-benzoyl-19&#x003b1;-hydroxy-3-oxo-urs-12-en-28-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">9.68</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">20.</td><td align="center" valign="middle" rowspan="1" colspan="1">Methoxy-Balanophonin</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">21.</td><td align="center" valign="middle" rowspan="1" colspan="1">Balanophonin</td><td align="center" valign="middle" rowspan="1" colspan="1">10.25</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">22.</td><td align="center" valign="middle" rowspan="1" colspan="1">Ilimaquinone</td><td align="center" valign="middle" rowspan="1" colspan="1">10.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">23.</td><td align="center" valign="middle" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" rowspan="1" colspan="1">10.63</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">24.</td><td align="center" valign="middle" rowspan="1" colspan="1">Oleuropein</td><td align="center" valign="middle" rowspan="1" colspan="1">11.17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">25.</td><td align="center" valign="middle" rowspan="1" colspan="1">Costic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">12.13</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">26.</td><td align="center" valign="middle" rowspan="1" colspan="1">(+)-lyoniresinol</td><td align="center" valign="middle" rowspan="1" colspan="1">12.31</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">27.</td><td align="center" valign="middle" rowspan="1" colspan="1">Holophyllane A</td><td align="center" valign="middle" rowspan="1" colspan="1">12.74</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">28.</td><td align="center" valign="middle" rowspan="1" colspan="1">Ilexgenin B</td><td align="center" valign="middle" rowspan="1" colspan="1">12.72</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">29.</td><td align="center" valign="middle" rowspan="1" colspan="1">3-O-cis-caffeoylbetulinic</td><td align="center" valign="middle" rowspan="1" colspan="1">13.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">30.</td><td align="center" valign="middle" rowspan="1" colspan="1">Daidzein</td><td align="center" valign="middle" rowspan="1" colspan="1">14.09</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">31.</td><td align="center" valign="middle" rowspan="1" colspan="1">Alphitolic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">14.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">32.</td><td align="center" valign="middle" rowspan="1" colspan="1">Dihydrodehydroconiferyl alcohol</td><td align="center" valign="middle" rowspan="1" colspan="1">14.6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">33.</td><td align="center" valign="middle" rowspan="1" colspan="1">Neonuezhenide</td><td align="center" valign="middle" rowspan="1" colspan="1">14.69</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">34.</td><td align="center" valign="middle" rowspan="1" colspan="1">Ilicic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">14.92</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">35.</td><td align="center" valign="middle" rowspan="1" colspan="1">Trichilinin B</td><td align="center" valign="middle" rowspan="1" colspan="1">15.28</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">36.</td><td align="center" valign="middle" rowspan="1" colspan="1">Eudeglaucone</td><td align="center" valign="middle" rowspan="1" colspan="1">15.9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">37.</td><td align="center" valign="middle" rowspan="1" colspan="1">(2&#x02033;R)-2&#x02033;- methoxyoleuropein</td><td align="center" valign="middle" rowspan="1" colspan="1">15.45</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">38.</td><td align="center" valign="middle" rowspan="1" colspan="1">Fraxetin</td><td align="center" valign="middle" rowspan="1" colspan="1">18.72</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">39.</td><td align="center" valign="middle" rowspan="1" colspan="1">1-desacetylnimbolinin B</td><td align="center" valign="middle" rowspan="1" colspan="1">18.75</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-NMMA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.53</td></tr></tbody></table></table-wrap></floats-group></article>